Ostreid Herpesvirus 1: Oyster Mortality Reference

Overview and Taxonomy of Ostreid Herpesvirus 1: Oyster Mortality Reference

Historical Context and Emergence as a Global Pathogen

Ostreid herpesvirus 1 (OsHV-1) represents a singularly devastating pathogen within the aquatic virological landscape, having fundamentally altered the trajectory of global bivalve aquaculture since its initial characterization in the early 1990s. The virus first garnered significant scientific attention during mortality events affecting Pacific oyster (Crassostrea gigas) populations in France, with systematic investigations confirming its association with catastrophic losses in hatchery-reared spat and juvenile oysters [38]. However, the epidemiological landscape shifted dramatically in 2008, when a novel genotype, designated OsHV-1 μVar (microvariant), emerged along the French coastline, precipitating mass mortality events of unprecedented scale and severity that rapidly propagated throughout European growing regions [1, 10]. This microvariant was distinguished from the reference genotype by specific deletions in the genomic region spanning open reading frames (ORFs) 4 and 5, alterations that conferred markedly enhanced virulence and transmissibility [38]. Within a remarkably compressed temporal window, OsHV-1 μVar displaced the ancestral reference genotype across European oyster-producing zones and subsequently disseminated to Australasia, the Americas, and Asia, establishing itself as a panzootic agent of paramount economic concern [1, 17]. The World Organisation for Animal Health (WOAH) has consequently listed OsHV-1 infection as a notifiable disease, underscoring its status as a transboundary pathogen requiring rigorous surveillance and biosecurity interventions. The emergence of OsHV-1 and its microvariants exemplifies the catastrophic potential of viral emergence in aquatic systems, where global movement of live animals, coupled with environmental perturbations, creates conditions favorable for pathogen establishment and spread [5, 21].

Taxonomic Classification and Virion Architecture

OsHV-1 occupies a singular phylogenetic position as a member of the family Malacoherpesviridae within the order Herpesvirales, representing one of only two herpesviruses known to infect invertebrate hosts [2, 18]. The family Malacoherpesviridae stands in distant evolutionary relation to the vertebrate-infecting Orthoherpesviridae (encompassing alpha-, beta-, and gammaherpesviruses) and the fish- and amphibian-infecting Alloherpesviridae, yet all members share a conserved virion architecture and fundamental aspects of replication biology [32]. The genus Ostreavirus accommodates OsHV-1 as its type species, a classification reflecting the virus’s unique adaptation to marine bivalve hosts [2]. The virion itself exhibits the characteristic herpesvirus morphology: an icosahedral nucleocapsid approximately 100–120 nm in diameter, enclosed within a lipid envelope derived from host cellular membranes, and housing a linear double-stranded DNA genome [20, 38]. Transmission electron microscopy of infected oyster tissues has consistently revealed enveloped particles arrayed within the cytoplasm and observed in association with nuclear alterations, underscoring the conserved nature of herpesvirus morphogenesis even across vast evolutionary distances [36, 38].

The OsHV-1 genome is a large double-stranded DNA molecule of approximately 207 kilobase pairs, a size comparable to that of certain vertebrate herpesviruses yet featuring a distinctive genomic architecture that confounded early sequencing efforts using short-read platforms [22, 30]. The genome is characterized by a complex arrangement including a unique long (UL) region flanked by inverted repeat sequences, with the presence of multiple genomic isomers resulting from recombination events during replication [22, 30]. This structural complexity, replete with tandem repeat regions and large structural variations, necessitated the adoption of third-generation sequencing technologies, notably Oxford Nanopore long-read sequencing, to achieve complete and accurate genome assemblies directly from infected host tissues without prior virus propagation [22, 30]. The annotated genome encodes approximately 78 to 124 predicted open reading frames (ORFs), depending on the bioinformatic pipeline and the specific variant under analysis, with functions spanning DNA replication and packaging, capsid assembly, envelope glycoprotein synthesis, and immunomodulation [10, 32]. Notably, the transcriptional landscape is remarkably intricate, with long-read transcriptomics revealing 274 distinct transcripts, including 67 polycistronic mRNAs, 35 non-coding RNAs, and 20 natural antisense transcripts (NATs), that collectively orchestrate viral replication and host interaction [32]. This transcriptional complexity is particularly pronounced for the capsid maturation module, where a conserved pan-Herpesvirales transcriptional architecture ensures the production of both a scaffold protein and a capsid maturation protease isoform through differential translation of a single polycistronic transcript, a feature that underscores the ancient evolutionary origins of herpesvirus replication strategies [32].

Genotypic Diversity and the Microvariant Paradigm

The genotypic landscape of OsHV-1 has undergone profound diversification since the emergence of the μVar lineage, with contemporary isolates exhibiting a spectrum of genetic variation that complicates classification and obscures genotype-phenotype correlations [1, 10]. The reference genotype (OsHV-1 Ref), historically associated with sporadic mortality and subclinical infections, is distinguished from microvariants by the absence of a 23-base pair deletion in ORF 4 and a 12-base pair deletion in ORF 5, alterations that are now considered diagnostic for μVar designation [10, 38]. However, subsequent surveillance efforts have uncovered an expanding array of microvariant genotypes, each exhibiting unique combinations of point mutations, insertions, and deletions distributed across the genome [1, 10, 21]. Phylogenetic analyses of ORF 42/43 sequences, together with interrogation of the hypervariable C region spanning ORFs 4 and 5, have facilitated the delineation of distinct genotypic clusters that often correlate with geographic origin and, in some cases, with pathogenic potential [2, 10, 21].

In Australia, for instance, comprehensive molecular epidemiological studies have revealed a relatively low diversity of OsHV-1 genotypes overall, yet distinct geographic clustering across estuarine systems, with genotypes from New South Wales forming a globally distinct cluster that does not conform to the European μVar paradigm [21]. This observation is pivotal: Australian Pacific Oyster Mortality Syndrome (POMS) outbreaks, while phenotypically indistinguishable from those caused by European μVar, are associated with genotypes that lack the canonical microvariant deletions, suggesting that alternative genomic determinants of virulence exist and that the term “microvariant” may be insufficiently precise for global classification [21]. Similarly, Japanese isolates (designated OsHV-1 JPType1) cluster phylogenetically as a distinct lineage with demonstrable pathogenicity for larval and juvenile oysters, though disease expression differs markedly from the European μVar pattern [23]. The discovery of a novel divergent μVar group in Normandy (France) in 2016, with an estimated evolutionary divergence of 0.0013 from previously characterized μVar isolates and unique polymorphisms in ORFs encoding putative membrane proteins, further illustrates the ongoing diversification of this viral lineage [10].

This genotypic diversity has tangible phenotypic consequences. Experimental comparisons of Australian OsHV-1 isolates collected between 2011 and 2015 revealed a statistically significant reduction in virulence over time, with the 2011 isolate inducing substantially higher cumulative mortality and hazard of death than isolates from 2014–2015 [1]. These differences were not attributable to disparities in viral load at death, suggesting that the observed attenuation reflects genuine variation in viral pathogenic mechanisms rather than differences in host-pathogen dose dynamics [1]. The isolation of low-virulence genotypes, including subclinical infections detected in sentinel oysters during periods when overt mortality was absent, raises the possibility that OsHV-1 populations may be evolving toward reduced virulence as they become endemic, a pattern reminiscent of the co-evolutionary dynamics observed in other host-pathogen systems [1, 8]. Nonetheless, the introduction of novel μVar genotypes into naïve oyster populations, such as the potential incursion of European or Australian μVar into US West Coast waters, remains a pressing concern, as the California reference genotype elicits substantially lower mortality than either the French or Australian μVar in comparative challenge trials [4, 17].

Host Range and Species Susceptibility

While the Pacific oyster Crassostrea gigas (also classified as Magallana gigas) constitutes the primary economically significant host and the species in which the most dramatic mortality events are documented, OsHV-1 exhibits a remarkably broad host range encompassing at least seven bivalve species across multiple families [9, 17]. Documented susceptible hosts include the European flat oyster Ostrea edulis, the Portuguese oyster Crassostrea angulata, the Eastern oyster Crassostrea virginica, the Kumamoto oyster Crassostrea sikamea, the bay scallop Argopecten irradians, and the blood clam Anadara broughtonii (also referred to as Scapharca broughtonii) [3, 9, 17, 19, 31, 33]. This host breadth raises substantial concerns for aquaculture biosecurity, particularly as the virus may circulate asymptomatically within certain carrier species and be transmitted horizontally to highly susceptible populations [9, 14]. Indeed, field surveys in Argentina detected OsHV-1 DNA in 70% of wild C. gigas samples from the Bahía Blanca Estuary, with 26.7% of oysters exhibiting macroscopic mantle lesions, confirming that the virus can establish infection in natural populations well beyond the boundaries of aquaculture operations [2]. Experimental challenges have further demonstrated that different oyster species and even different stocks within a species exhibit profoundly divergent susceptibilities to infection and mortality [17]. For example, C. gigas stocks challenged with French μVar displayed mortality ranging from 72% to 90%, while C. sikamea mortality was only 22% under identical conditions; intriguingly, the patterns reversed when stocks were challenged with Australian μVar, indicating that host genetics and virus genotype interact in complex, non-additive ways to determine disease outcome [17]. Single stocks of Eastern oysters and hard clams (Mercenaria mercenaria) were refractory to disease when exposed to μVar through natural waterborne routes, yet Eastern oysters could mechanically transmit the virus to naïve Pacific oysters following intramuscular injection, highlighting the potential for subclinically infected native species to serve as bridging vectors [9].

Transmission Dynamics, Environmental Triggers, and the Polymicrobial Nature of Disease

The epidemiology of OsHV-1 infection is inextricably linked to environmental variables, most notably temperature, salinity, and nutrient availability, that modulate both host susceptibility and pathogen replication kinetics [5, 8, 12, 24, 27]. Water temperature constitutes the single most critical determinant of disease expression, with a well-characterized threshold lying between 14°C and 18°C below which productive viral infection does not occur [24, 35]. Experimental challenge studies have demonstrated unequivocally that juvenile oysters maintained at 14°C show no mortality even when injected with high viral doses, while oysters acclimated to 22°C or 26°C experience 77–84% mortality [24]. Intriguingly, high temperature (>30°C) can paradoxically protect oysters by inducing metabolic reprogramming and enhanced antiviral immune capacity that limits POMS development [29]. The temperature dependence of infection has profound implications for disease management: in Australian estuaries, mortality due to OsHV-1 commences when mean water temperature rises above approximately 20°C, substantially warmer than the 16°C threshold reported in Europe, suggesting that local adaptation of viral strains or host populations influences thermal permissiveness [8]. Analysis of index cases (first disease appearances) in Australia between 2010 and 2024 revealed that each was preceded by unusually low rainfall and elevated rates of temperature change, implicating thermal flux as a stressor that may increase oyster susceptibility independently of absolute temperature [5].

Salinity exerts similarly complex effects on disease outcome. Oysters acclimated to low salinity (10‰) exhibit 95% survival following OsHV-1 exposure, compared to only 43–73% survival at higher salinities (25–35‰), an effect that correlates with reduced viral DNA levels and decreased viral gene expression [12]. However, the protective effect of low salinity disappears when oysters are not properly acclimated: non-acclimated oysters exposed to an acute salinity shock show only 23% survival, with mortality attributable to osmotic stress rather than viral replication per se [12]. Mechanistically, salinity influences disease susceptibility through modulation of host energetics and antioxidant capacity; oysters with higher superoxide dismutase activity and elevated levels of protein, carbohydrate, and triglyceride reserves are at reduced risk of death, suggesting that physiological condition, itself shaped by environmental salinity, is a critical determinant of host resilience [37].

The complexity of OsHV-1 pathogenesis is compounded by its role as the initiator of Pacific Oyster Mortality Syndrome (POMS), a polymicrobial disease in which the viral infection breaches host defenses, permitting secondary invasion by opportunistic bacteria, particularly Vibrio species, that ultimately precipitate lethal septicemia [28, 34]. Dual transcriptomic and microbiome analyses have revealed a characteristic sequence: OsHV-1 infection induces tissue damage and immunosuppression, leading to a measurable increase in bacterial richness in the oyster microbiome, followed by a collapse of bacterial diversity as moribund animals transition to a Vibrio-dominated state [28, 34]. Four bacterial taxa, Arcobacter, Vibrio, Amphritea, and Pseudoalteromonas, have been consistently associated with terminal POMS irrespective of geographic location or microvariant genotype, suggesting a conserved polymicrobial cascade [28]. This bacterial succession is not merely a terminal epiphenomenon; rather, it represents an integral component of disease progression, as antimicrobial interventions or microbiome manipulations can alter mortality outcomes independently of viral load [34].

Immune Interactions, Viral Evasion, and Host Genetic Determinants

The Pacific oyster lacks a classical adaptive immune system and therefore relies entirely on innate defense mechanisms to counter OsHV-1 infection [11, 13, 25, 36]. Despite this limitation, the oyster immune system exhibits a remarkable capacity for immune priming, a form of innate memory whereby prior exposure to a pathogen or pathogen-associated molecular pattern (PAMP) confers enhanced protection upon secondary challenge [6, 15, 16, 35]. Laboratory studies have demonstrated that a single non-lethal exposure to infectious OsHV-1 at 18°C, a temperature permissive for viral replication but not for mortality, reduces the hazard of death upon subsequent lethal challenge at 22°C by 78% (hazard ratio 0.22) [35]. Even more strikingly, heat-inactivated OsHV-1 and the synthetic double-stranded RNA analog poly(I:C) both induce significant protection, with hazard ratios of 0.41 and 0.02, respectively, indicating that viral replication is not required for the induction of a protective innate response [16]. This phenomenon has been extended transgenerationally: maternal, but not paternal, exposure to poly(I:C) improves larval survival to OsHV-1 challenge, likely through provisioning of antiviral compounds in the egg [26].

The molecular basis of antiviral immunity in oysters involves a sophisticated network of pattern recognition receptors (PRRs), signaling cascades, and effector mechanisms that bear striking functional similarity to vertebrate innate immune pathways [7, 13, 25]. Toll-like receptors (TLRs) and retinoic acid-induc

Molecular Pathogenesis of OsHV-1 Infection in Pacific Oysters

The molecular pathogenesis of Ostreid herpesvirus 1 (OsHV-1) in Pacific oysters (Crassostrea gigas, now frequently reclassified as Magallana gigas) represents a paradigm of host-pathogen-environment interaction that is both exquisitely complex and devastatingly efficient. As a member of the Malacoherpesviridae family within the order Herpesvirales, OsHV-1 is one of only two known herpesviruses to infect invertebrates, yet its impact on global aquaculture is profound, causing mass mortality events that can exceed 90% in susceptible juvenile stocks [4, 9, 28]. The disease, formally termed Pacific Oyster Mortality Syndrome (POMS), is not a simple viral infection but a polymicrobial cascade initiated by the virus, which subsequently compromises host defenses to allow fatal secondary bacterial infections, primarily by Vibrio spp. [28, 34]. Understanding the molecular pathogenesis requires dissecting the virus's life cycle, its sophisticated manipulation of host cellular machinery, the genetic determinants of host susceptibility, and the critical role of environmental co-factors that modulate the trajectory from exposure to mortality.

Viral Entry, Cellular Tropism, and Initial Replication

The initial steps of OsHV-1 infection are predicated on the virus gaining access to permissive host cells. The primary route of natural infection is horizontal, likely via the water column, with the virus entering through the pallial cavity and across the epithelia of the gills and mantle [19, 20]. Once inside the host, the virus demonstrates a distinct cellular tropism. In situ hybridization (ISH) and quantitative PCR studies have consistently identified hemocytes and fibroblastic-like cells of the connective tissues as the primary cellular targets [19]. Hemocytes are the central effectors of the oyster's innate immune system, and their infection is a critical pathogenic event, effectively turning the host's own defense force into a vehicle for viral replication and dissemination throughout the body [19, 36]. The virus then spreads to the connective tissues of all major organs, including the mantle, hepatopancreas, gills, and adductor muscle, with viral loads increasing exponentially, often peaking between 48 and 72 hours post-infection (hpi) in susceptible individuals [19, 46].

The replication strategy of OsHV-1, while sharing a core architecture with other herpesviruses, reveals unique adaptations. The genome, a large double-stranded DNA molecule of approximately 207 kbp, is characterized by a complex architecture with multiple genomic isomers, a feature that has historically complicated assembly using short-read sequencing but is now being resolved through long-read nanopore technologies [22, 30]. Transcriptomic analyses using long-read RNA sequencing have unveiled a remarkably complex transcriptome comprising 78 gene units and 274 distinct transcripts, including 67 polycistronic mRNAs, 35 non-coding RNAs, and 20 natural antisense transcripts (NATs) [32]. A key finding is the conservation of a pan-Herpesvirales transcriptional architecture for the capsid maturation module, where the capsid scaffold protein is preferentially transcribed and independently translated as a protease isoform, underscoring a functionally critical and evolutionarily ancient mechanism for virion assembly [32]. The replication cycle is temperature-dependent, with a clear threshold between 14°C and 18°C. At 14°C, productive infection is essentially aborted, with minimal viral DNA replication and no mortality, whereas at 22°C and above, the virus replicates aggressively, leading to high mortality [24, 35]. This temperature dependency is a cornerstone of the disease's epidemiology, dictating its seasonal occurrence in temperate waters [5, 8].

Subversion of Host Antiviral Defenses: Apoptosis, Autophagy, and RNA Interference

The success of OsHV-1 as a pathogen hinges on its ability to evade or subvert the host's innate immune arsenal. The Pacific oyster lacks an adaptive immune system in the classical vertebrate sense, relying entirely on innate mechanisms, including apoptosis, autophagy, RNA interference (RNAi), and an interferon-like pathway [13, 25, 36].

Apoptosis is a frontline antiviral defense, serving to eliminate infected cells and limit viral spread. However, OsHV-1 has evolved potent anti-apoptotic strategies. Studies on hemocytes from infected oysters have demonstrated a clear inhibition of the apoptotic process at both molecular and cellular levels. At 24 and 48 hpi, there is a significant down-regulation of pro-apoptotic genes, including tumor necrosis factor (TNF) and caspase 3, coupled with an up-regulation of anti-apoptotic genes such as IAP-2 (inhibitor of apoptosis) and Bcl-2 [36]. Furthermore, the OsHV-1 genome itself encodes a putative apoptosis inhibitor (ORF 87), whose transcription is significantly upregulated during infection, providing a direct viral mechanism to block this host defense [36]. This subversion allows infected hemocytes to survive longer, providing a protected niche for viral replication.

Autophagy, a cellular degradation pathway involved in clearing intracellular pathogens, also plays a dual role. While it can act as an antiviral mechanism, OsHV-1 appears to manipulate it to its advantage. Experimental infections have shown activation of autophagy in hemolymph and mantle tissue at 14 hpi, coinciding with the onset of viral replication [40]. However, comparative proteomics between resistant and susceptible oyster families suggests that in highly susceptible oysters, OsHV-1 manipulates the autophagy system, potentially hijacking it to provide membrane scaffolds for viral replication or to degrade host antiviral factors, thereby weakening the host and triggering death [13]. The use of autophagy modulators in experimental settings has confirmed the pathway's involvement, but its precise role, whether protective or detrimental, is context-dependent and likely varies with the host's genetic background and the stage of infection [40].

RNA interference (RNAi) is a critical antiviral pathway in invertebrates. The injection of long double-stranded RNA (dsRNA) molecules, even those targeting a non-specific gene like GFP, has been shown to induce a potent anti-viral state in oysters, dramatically suppressing OsHV-1 replication and conferring near-complete survival [42]. This effect is mediated by the activation of key immune genes, including Cg-IκB1, Cg-Rel1, Cg-IFI44, Cg-PKR, and Cg-IAP, which collectively hamper viral replication [42]. This finding has profound implications, as it demonstrates that the host RNAi machinery is a powerful antiviral force that can be therapeutically stimulated.

A more recently discovered and fascinating layer of host-virus interaction involves Adenosine Deaminase Acting on RNA (ADAR) . ADAR enzymes catalyze the conversion of adenosine to inosine (A-to-I) in double-stranded RNA, a process known as RNA editing. During OsHV-1 infection, there is a marked increase in ADAR1 expression and hyper-editing activity on both host and viral transcripts [44]. The virus appears to have evolved a counter-defense mechanism to evade this system. Long-read transcriptomics revealed that OsHV-1 generates "molecular decoys" by co-expressing sense-antisense transcripts. These double-stranded RNA structures sequester the majority of ADAR hyper-editing activity, thereby protecting essential viral open reading frames from detrimental editing and facilitating evasion of this host antiviral system [32].

The Role of the Interferon-Like Pathway and Toll-Like Receptor Signaling

Despite the absence of a classical interferon system, oysters possess an analogous pathway involving key signaling molecules. Comparative proteomics has confirmed the implication of proteins involved in an interferon-like pathway as crucial for efficient antiviral defenses [13]. Central to this is the Toll-like receptor (TLR) signaling cascade. The oyster genome encodes a complex repertoire of TLRs and MyD88 adaptor proteins. A critical regulatory mechanism has been elucidated involving a unique splice variant, CgMyD88s, which contains only a TIR domain and lacks the death domain. This protein acts as a "plug" in the TLR pathway. During OsHV-1 infection, the expression of the full-length activators CgMyD88-1 and CgMyD88-2 is upregulated, while CgMyD88s is downregulated [25]. CgMyD88s interacts only with CgTLR and not with the other MyD88s, and it impairs the NF-κB activation induced by CgMyD88-1 and CgMyD88-2. Silencing CgMyD88s via RNAi leads to increased expression of the full-length forms, suggesting that this splice variant is a critical negative regulator that prevents an excessive, potentially damaging inflammatory response during viral infection [25]. This fine-tuning of the innate immune response is essential for host survival.

Genetic Determinants of Susceptibility and Resistance

The outcome of OsHV-1 infection is heavily influenced by host genetics. Selective breeding programs have demonstrated significant heritable variation in survival, with some oyster families showing markedly lower mortality than others [4, 39, 46]. Genome-wide association studies (GWAS) and pooled resequencing have identified several quantitative trait loci (QTL) and candidate genes associated with resistance. A major QTL on chromosome 8 has been repeatedly identified [7, 11]. Within this region, candidate genes such as ABCA1, PIK3R1, and WBP2 have been pinpointed, all of which are known to play roles in antiviral innate immunity in vertebrates [7]. This striking conservation of antiviral gene function across the animal kingdom reinforces the deep evolutionary roots of the innate immune system.

Interestingly, resistance does not always equate to resistance to infection (the ability to prevent or clear the virus). Many surviving oysters from lethal challenges harbor extremely high viral loads (mean ~3.53 × 10⁸ copies), indicating that they are tolerant rather than resistant [4]. They can tolerate the presence of the virus without succumbing to disease. This distinction is critical for breeding programs, as selecting solely for survival might inadvertently select for tolerance, which could maintain a reservoir of highly infectious individuals in the population [4]. Furthermore, the genetic basis of resistance differs between life stages. Pooled resequencing of larvae and adults revealed that only 1,653 of the genes associated with mortality were shared between the two stages, suggesting that the antiviral response in larvae and adults involves different sets of genes or differentially regulated members of expanded gene families [11].

The Polymicrobial Cascade and Environmental Modulation

The final, lethal phase of POMS is not solely due to viral cytopathology. OsHV-1 infection precipitates a breakdown in host homeostasis, particularly in the hemolymph and tissues, which allows for the uncontrolled proliferation of opportunistic bacteria, most notably Vibrio species [28, 34]. A strong correlation exists between OsHV-1 and Vibrio loads in moribund oysters, and the microbiome of infected oysters undergoes a dramatic shift, with a decrease in bacterial richness and an increase in specific taxa like Arcobacter, Vibrio, Amphritea, and Pseudoalteromonas [28, 34]. This polymicrobial nature is a defining feature of POMS.

Environmental factors are the ultimate arbiters of this molecular pathogenesis. Temperature is the most critical, acting as a master switch. As detailed, permissive temperatures (>18°C) are required for viral replication and disease expression [24, 28]. However, the relationship is not linear. Paradoxically, very high temperatures (30°C) can be protective, inducing a metabolic reprogramming in the oyster that creates a sub-optimal environment for viral replication and enhances baseline antiviral immunity [29]. Salinity also plays a modulating role. Low salinity (10‰) can protect oysters by reducing viral infectivity and transmission, but this effect is confounded by the physiological stress of osmotic shock, which can itself be lethal [12, 37]. Nutritional status is another powerful modulator. Starvation has been shown to reduce susceptibility to POMS by inducing metabolic rate depression, which limits the energy available for viral hijacking, and by enhancing autophagy and antiviral responses [43]. Conversely, exposure to environmental pollutants like pesticides can increase susceptibility by compromising the oyster's physiological condition [45]. Even tidal emersion has complex effects; while field studies suggested a protective effect, laboratory studies showed that constant immersion can be protective for infected adults, likely by preventing desiccation stress and allowing recovery [41].

In conclusion, the molecular pathogenesis of OsHV-1 is a multi-stage, highly regulated process. It begins with viral entry and replication in hemocytes, proceeds through the sophisticated subversion of apoptosis, autophagy, and ADAR defenses, and is critically dependent on the host's genetic background and the prevailing environmental conditions. The ultimate cause of death is not the virus alone, but the virus-induced collapse of immune surveillance that permits a fatal secondary bacteremia. This intricate interplay of viral virulence factors, host genetics, and environmental stressors explains the variable and often unpredictable nature of POMS outbreaks, and highlights the need for integrated management strategies that target the entire pathosystem.

Epidemiology and Global Distribution of OsHV-1 Microvariants

The emergence of Ostreid herpesvirus 1 (OsHV-1) microvariants (µVars) represents one of the most significant panzootic events in the history of molluscan aquaculture, constituting a paradigm-shifting challenge for global bivalve production. These genotypes, first recognized during catastrophic mortality events in Crassostrea gigas spat in France during the summer of 2008, rapidly displaced the previously dominant OsHV-1 reference genotype and established an epidemiological trajectory that would ultimately encircle the globe [1, 38]. The initial outbreaks in France, characterized by acute mortalities exceeding 80–100% in affected cohorts, were linked to a specific variant, OsHV-1 µVar, which exhibited a deletion in the microsatellite region of the C2/C6 genomic area [10, 38]. This sentinel event catalyzed an international research response, as the virus subsequently disseminated to virtually all major Pacific oyster producing regions, including Ireland, the United Kingdom, Spain, Portugal, the Netherlands, Australia, New Zealand, and, more recently, the United States, Asia, and South America [2, 4, 9, 31]. The World Organisation for Animal Health (WOAH) has consequently listed OsHV-1 infection as a notifiable disease, underscoring its status as a pathogen of critical economic and food security importance.

The global dissemination of OsHV-1 microvariants cannot be understood without appreciating the intricate interplay between viral genetic diversity, host population dynamics, and anthropogenic transport pathways. Phylogenetic and phylogeographic analyses have consistently implicated the movement of live oysters, both for on-growing and for hatchery broodstock, as the primary vector for intercontinental and inter-regional spread [47]. Ultra-deep sequencing of OsHV-1 genomes from French farming areas has provided compelling evidence that the Marennes-Oléron Bay functions as a principal reservoir and source population, from which viral variants have radiated to other production zones via the extensive network of oyster transfers that characterizes European aquaculture [47]. This pattern is mirrored globally: the introduction of OsHV-1 microvariants to Australia in 2010, for instance, was followed by a stepwise expansion through New South Wales estuaries, with distinct geographical clustering of genotypes observed in the Georges River, Hawkesbury River, and Clyde River systems [5, 21, 48]. Crucially, genomic characterization of Australian isolates revealed a relatively low diversity of OsHV-1 genotypes that formed a globally distinct cluster, and notably, many Australian outbreaks were not attributable to the classical ORF4 deletion-defined microvariants, suggesting the existence of locally evolving pathogenic lineages [21]. This finding challenges the notion of a single, monolithic "microvariant" and underscores the necessity of continuous genomic surveillance.

Seasonal patterns of OsHV-1 microvariant epidemics are remarkably consistent across disparate geographic regions, a phenomenon that reflects the profound influence of water temperature on viral pathogenesis. In Australia, longitudinal sentinel studies conducted between 2012 and 2017 across 15 sites in two large estuaries demonstrated that mortality commenced when mean water temperatures exceeded approximately 20°C in spring, a threshold significantly higher, by 4–5°C, than the initiation temperature reported in European studies [8]. Mortality was most widespread and frequent between December and April (austral summer), with subclinical infections detected as early as October and as late as June [8]. Critically, this work revealed substantial inter-annual variation in disease severity, with a significant reduction in both mortality and subclinical infection prevalence observed between the 2012–13 and 2016–17 seasons, accompanied by declining viral loads in infected oysters [8]. These temporal patterns correlate with independent observations from Australia demonstrating a reduction in the virulence of OsHV-1 isolates over time; isolates obtained in 2011 induced significantly higher cumulative mortality and hazard of death in laboratory challenges compared to isolates from 2014–15, despite similar viral loads at the time of death [1]. Such data suggest that co-evolutionary processes may be attenuating the virulence of newly emerged microvariants as they transition from epidemic to endemic status, a phenomenon with profound implications for long-term disease management and the potential for controlled exposure strategies.

The index cases of Pacific Oyster Mortality Syndrome (POMS) in Australia, occurring in 2010, 2013, 2016, and 2024, provide a unique opportunity to investigate the environmental conditions that precede a viral emergence event. Whittington et al. (2024) conducted a comparative analysis of these four index cases and found that water temperature alone was not a consistent predictor [5]. Rather, each index case was preceded by a period of unusually low rainfall and higher rates of temperature change, which may act as proxies for thermal flux stress that could increase oyster susceptibility [5]. Tidal cycles and chlorophyll-a levels were unremarkable, while harmful algal blooms were present during all events. The authors concluded that the lack of a consistent, interpretable change in the estuarine environment favored the hypothesis of recent viral introduction over emergence from a local reservoir, although the latter could not be excluded [5]. These findings underscore the stochastic nature of viral incursions into naive populations and highlight the difficulty of predicting future events based solely on environmental monitoring.

The geographic expansion of OsHV-1 microvariants into the Americas represents a more recent and concerning development. The virus was first detected in Tomales Bay, California, where a non-µVar reference-like strain had been enzootic for years [17, 39]. However, experimental challenges demonstrated that the introduction of French (FRA) or Australian (AUS) microvariants could have catastrophic consequences for US oyster populations. When naive Pacific oyster families were exposed, survival probability was significantly lower for the French (43%) and Australian (71%) microvariants compared to the California reference strain (96%), and critically, no single oyster family demonstrated resistance to all three variants [4]. Furthermore, many surviving oysters harbored extremely high viral loads (mean ~3.53 × 10⁸ copies), indicating tolerance to infection rather than true resistance [4]. This distinction is epidemiologically crucial: tolerant carriers may serve as undetected reservoirs, facilitating viral persistence and transmission. More recently, the San Diego Bay microvariant was detected in juvenile Pacific oysters, with experimental infections demonstrating that while the virus could replicate at temperatures as low as 15°C, mortality only occurred at 18°C and above [28]. Importantly, this study revealed a conserved pattern of bacterial dysbiosis, involving Arcobacter, Vibrio, Amphritea, and Pseudoalteromonas, that mirrored findings from microvariant infections globally, suggesting that polymicrobial interactions are a hallmark of OsHV-1 pathobiology irrespective of geographic origin [28].

The detection of OsHV-1 in Argentina in 2017 marked the first confirmation of the virus in wild C. gigas populations in South America [2]. Sampling from Bahía Blanca Estuary revealed a 70% prevalence of OsHV-1 DNA by PCR, with 26.7% of oysters exhibiting macroscopic mantle lesions [2]. Sequencing confirmed 99% identity to both the OsHV-1 reference and µVar strains from France and Ireland, demonstrating the ongoing global propagation of these genotypes. This finding, coupled with the detection of OsHV-1 in bay scallops (Argopecten irradians) in Korea, where over 90% larval mortality occurred in hatcheries, underscores the expanding host range of microvariants beyond Pacific oysters [31]. The Korean isolates showed 99% sequence identity to European microvariants in the ORF4 region, suggesting a potential transcontinental introduction pathway, possibly through international trade of live bivalves [31]. Similarly, surveillance in the Chesapeake Bay and Maryland coastal bays of the USA found no evidence of OsHV-1 in eastern oysters (C. virginica) or hard clams (Mercenaria mercenaria) despite experimental studies demonstrating that eastern oysters could horizontally transmit the virus to naive Pacific oysters when injected, raising concerns about their potential role as asymptomatic carriers [9].

The role of non-target species and invasive non-native species (INNS) as vectors for OsHV-1 microvariant dissemination represents an underexplored but potentially critical transmission pathway. A comprehensive survey of estuarine invertebrates, including Crustacea, Mollusca, Polychaeta, Tunicata, and Porifera, in Ireland detected OsHV-1 µVar DNA in 7.7% of samples, with detection in shore crabs (Carcinus maenas), polychaetes, and mussels (Mytilus spp.) at sites without active oyster culture [14]. Strikingly, 51.1% of recently dead shore crabs harbored either OsHV-1 µVar or Vibrio spp., and OsHV-1 µVar detection was significantly higher in dead crabs (24.4%) compared to living crabs (5.9%) [14]. The virus was also detected in mussels at an average sea surface temperature of just 11.25°C, far below the typical permissive threshold for disease expression in Pacific oysters. These findings have profound epidemiological implications: INNS, whose geographic ranges are expanding due to climate change and maritime traffic, may function as mobile reservoirs or mechanical vectors, facilitating the spread of OsHV-1 microvariants to naive oyster populations even when environmental conditions are suboptimal for disease expression in the primary host.

The genetic diversity of OsHV-1 microvariants, far from being static, continues to evolve in a manner that challenges both diagnostic and management strategies. Sequencing of 30 open reading frames (ORFs) from twenty OsHV-1-positive individuals in Normandy, France, revealed seven distinct genotypes, with the highest number of variations occurring in ORFs encoding putative membrane proteins [10]. Phylogenetic analysis identified a well-separated µVar new group, with an estimated evolutionary divergence of 0.0013 from other µVar variants, providing evidence for ongoing diversification [10]. This genetic plasticity is further evidenced by the discovery of a Japanese variant, OsHV-1 JPType1, which exhibited differential pathogenicity across oyster life stages, D-shaped larvae were far more susceptible than pediveliger larvae, and pathogenicity declined with spat growth, suggesting that genotype-by-stage interactions are a critical feature of viral epidemiology [23]. The recent application of long-read sequencing technologies, including Oxford Nanopore adaptive sampling, has revolutionized our ability to characterize this diversity directly from infected tissues, revealing complex genomic architectures with multiple isomers that short-read platforms cannot resolve [22, 30]. These methodological advances will be essential for tracking the emergence of novel microvariants and for understanding the landscape of viral diversity in endemic regions.

The environmental modulation of OsHV-1 microvariant epidemiology extends beyond temperature to encompass salinity, pH, nutritional status, and anthropogenic contaminants. Experimental studies have demonstrated that low salinity (10‰) can dramatically reduce disease-induced mortality, from as high as 73% at 25–35‰ to just 5% in acclimated oysters, by limiting viral replication and gene expression [12, 37]. However, this protective effect is contingent on prior acclimation; non-acclimated oysters subjected to salinity shock exhibited high mortality even at low salinity, suggesting that physiological stress overrides any direct effect on the virus [12]. Low seawater pH (7.8) similarly increased mortality in OsHV-1-infected oysters compared to ambient pH (8.1), despite equivalent viral loads, an effect attributed to reduced activity of superoxide dismutase and nitric oxide synthase, key components of the antiviral oxidative burst [27]. Even nutritional status has been shown to modulate disease outcome: food deprivation (starvation) paradoxically enhanced resistance to POMS by inducing metabolic rate depression and upregulating autophagy and antiviral pathways, creating a sub-optimal environment for viral replication [43]. These multifactorial interactions emphasize that the epidemiology of OsHV-1 microvariants cannot be reduced to a single risk factor but must be understood as a complex systems-level phenomenon in which host physiology, environmental conditions, and viral genetics converge.

In a finding of particular relevance to global trade and biosecurity, studies on the effect of emersion, a standard practice in intertidal oyster culture, have yielded counterintuitive results that challenge established management recommendations. While field observations in Australia suggested that higher intertidal growing heights (300 mm above standard) reduced mortality, controlled laboratory experiments demonstrated that emersion actually increased mortality in infected adult oysters (67.2%) compared to constant immersion (11.3%) [41]. The authors proposed that the field-based protective effect of high growing height likely results from reduced exposure to the virus rather than any physiological benefit conferred by emersion, and that if infected oysters can be continuously immersed with control of predators and secondary infections, many may survive [41]. This insight has direct implications for farm-level management during outbreak periods and illustrates the importance of distinguishing between mechanisms of exposure avoidance and mechanisms of disease resistance.

The detection and quantification of OsHV-1 in seawater, a critical tool for early warning systems and epidemiological forecasting, has been significantly advanced by method developments such as anionic polymer-coated magnetic beads for viral pre-concentration. This approach achieved a limit of detection as low as 0.1 viral copy/μL, 100-fold lower than qPCR alone, and was used to demonstrate that UV disinfection at 1360 J/m² effectively eliminated detectable virus from seawater [20, 49]. The ability to monitor viral kinetics in the water column will be essential for understanding transmission dynamics and for evaluating the efficacy of biosecurity interventions, including depuration and hatchery water treatment.

Host genetic factors exert a powerful influence on the epidemiology of OsHV-1 microvariants, shaping both individual susceptibility and population-level disease dynamics. Selection experiments have demonstrated significant genetic variation for survival, and quantitative trait locus (QTL) mapping has identified a major QTL on chromosome 8 associated with basal antiviral gene expression and survival in Tomales Bay, California [7]. Fine-mapping within this region implicated three candidate genes, ABCA1, PIK3R1, and WBP2, all of which have established roles in vertebrate antiviral innate immunity, reinforcing the evolutionary conservation of antiviral pathways across host taxa [7]. However, the relationship between host genetics and viral diversity is complex: pooled resequencing of larvae and adults revealed that only 1,653 of the genes significantly associated with herpesvirus-caused mortality were shared between life stages, suggesting that the genetic architecture of resistance differs between larvae and adults [11]. This developmental stage specificity has profound epidemiological consequences, as management strategies that prove effective for spat may not translate to adult populations, and vice versa.

The phenomenon of immune priming, whereby prior exposure to sub-lethal doses of OsHV-1 or even inactivated viral preparations confers protection against subsequent lethal challenge, has emerged as a potential avenue for disease management and has significant implications for understanding herd immunity in natural populations. Laboratory studies demonstrated that prior exposure to OsHV-1 at 18°C reduced the hazard of death upon re-exposure at 22°C by 78% compared to naive controls [35]. This protection was not dependent on viral replication during the initial exposure, as heat-inactivated OsHV-1 and poly I:C (a double-stranded RNA mimic) also induced significant protection, with hazard ratios of 0.41 and 0.02, respectively [16]. Furthermore, transgenerational immune priming has been documented: oyster larvae had higher survival to OsHV-1 when their mothers, but not their fathers, were exposed to poly I:C prior to spawning, likely via maternal provisioning of antiviral compounds in the eggs [26]. These findings suggest that the epidemiology of OsHV-1 microvariants in endemic regions may be substantially modulated by the immunological history of the host population, with naive cohorts experiencing elevated mortality relative to those with prior exposure.

Finally, the potential for anthropogenic chemicals to alter host susceptibility to OsHV-1 microvariants represents an emerging concern in coastal environments. Experimental exposure of Pacific oysters to a mixture of 14 pesticides at environmentally realistic concentrations resulted in higher mortality rates following OsHV-1 challenge compared to unexposed controls, despite the pesticides having no direct effect on viral capsid integrity [45]. This suggests that chemical contaminants can exert adverse effects on oyster physiology that increase susceptibility to viral infection, potentially contributing to spatial heterogeneity in disease risk within and between estuaries.

Diagnostic Methods for OsHV-1 Detection and Quantification

The accurate detection and quantification of Ostreid herpesvirus 1 (OsHV-1) and its microvariants are fundamental for understanding the epidemiology, pathogenesis, and ecology of this economically devastating pathogen of bivalve mollusks. As a large double-stranded DNA virus belonging to the family Malacoherpesviridae within the order Herpesvirales, OsHV-1 cannot be propagated in continuous cell lines, a characteristic that has historically constrained diagnostic development. Consequently, the diagnostic arsenal for OsHV-1 has evolved almost exclusively around nucleic acid-based techniques, supported by histopathology, electron microscopy, and, more recently, biosensor and genomic sequencing technologies. The World Organisation for Animal Health (WOAH) lists OsHV-1 infection as a notifiable disease for aquatic animals, underscoring the critical need for standardized, validated diagnostic protocols for surveillance, trade, and disease control [8, 48]. This section provides an exhaustive examination of the diagnostic methods employed for OsHV-1 detection and quantification, from established molecular assays to cutting-edge sequencing and point-of-care platforms, with emphasis on their applications, limitations, and interpretive frameworks.

Molecular Detection: PCR-Based Methods

Conventional PCR and End-Point Detection

The earliest molecular detection of OsHV-1 relied on conventional PCR targeting conserved regions of the viral genome. Primer pairs such as C2/C6, which amplify a region within the viral genome, and IA1/IA2, which target ORF42/43, have been widely used for diagnostic screening and initial genotyping [2, 3, 31]. These assays provided the first confirmatory evidence of OsHV-1 in wild populations, such as the detection of the virus in Crassostrea gigas from Argentina [2] and its identification in bay scallops (Argopecten irradians) in Korea [31]. Sequencing of conventional PCR amplicons has been instrumental in characterizing viral variants and confirming the presence of microvariant genotypes [10, 21]. However, conventional PCR is inherently qualitative or semi-quantitative at best, lacks the sensitivity required to detect low-level infections common in subclinical carriers or environmental samples, and is not suitable for precise viral load determination. These limitations have largely relegated conventional PCR to a supporting role in genotyping confirmation, while quantitative real-time PCR has become the gold standard for routine diagnosis and quantification.

Quantitative Real-Time PCR (qPCR)

Quantitative real-time PCR (qPCR) is the most widely used and validated method for OsHV-1 detection and quantification. Targeting various open reading frames (ORFs), most commonly ORF4, ORF25, ORF72, or the C region, qPCR assays provide both the presence or absence of viral DNA and the absolute number of viral genome copies per unit of host tissue or DNA [4, 8-10, 12, 17, 19, 20, 23, 24, 28, 34, 36, 38, 39, 41, 46, 48, 49, 53]. TaqMan probe-based assays offer greater specificity than SYBR Green-based methods, though both chemistries have been successfully employed. The ability to quantify viral load is critical because disease severity and mortality in Pacific oysters are strongly correlated with the concentration of OsHV-1 DNA; peak viral loads in moribund oysters typically range from 10⁶ to 10⁹ copies per ng of total DNA or per mg of tissue [4, 17, 24, 36]. Conversely, survivors of outbreaks often carry lower viral loads or harbor the virus subclinically, a phenomenon that underpins the distinction between resistance (limiting viral replication) and tolerance (surviving despite high viral loads) [4, 8]. qPCR has been applied extensively in experimental challenge studies to monitor viral kinetics over time [12, 24, 40], in field surveillance to estimate prevalence and spatial distribution [8, 39, 48], and in diagnostic workflows to confirm OsHV-1 as the cause of mortality events [9, 48]. However, qPCR cannot discriminate between infectious and non-infectious viral particles; it detects both encapsulated virions and free genomic DNA released from degraded particles or lysed cells. To partially address this, propidium monoazide (PMA) pre-treatment prior to qPCR has been used to selectively amplify DNA from intact virions, as demonstrated in studies evaluating pesticide effects on viral integrity [45]. Despite this refinement, qPCR remains the cornerstone of OsHV-1 diagnostics.

Reverse Transcription qPCR (RT-qPCR) for Viral RNA

Because qPCR detects DNA that may persist in the environment or in non-replicating states, the assessment of active viral replication requires the detection of viral RNA. Reverse transcription qPCR (RT-qPCR) targeting viral transcripts, particularly those encoding immediate-early and early genes such as ORF25, ORF41, ORF72, ORF75, and ORF87, provides a measure of ongoing viral gene expression and, by extension, productive infection [12, 20, 32, 36, 40, 46]. In experimental infections, the detection of viral RNA precedes the exponential increase in viral DNA and is correlated with the onset of clinical signs and mortality [36, 40]. The use of RT-qPCR has been instrumental in elucidating the viral replication cycle, demonstrating the upregulation of putative membrane proteins and a viral apoptosis inhibitor during infection [36], and in evaluating the efficacy of antiviral treatments such as berberine, which suppresses transcript levels of early enzymes and nucleocapsid proteins [50]. Furthermore, the absence of viral RNA in oysters with detectable DNA supports the existence of a latent or persistent infection state, as viral genomes may remain quiescent without active transcription [51]. Thus, RT-qPCR is a powerful complement to DNA-based qPCR for distinguishing active from latent infections, though its application is more technically demanding due to the instability of RNA and the need for rigorous DNase treatment.

Droplet Digital PCR (ddPCR)

Droplet digital PCR (ddPCR) offers an alternative to qPCR for absolute quantification without the need for standard curves. By partitioning the sample into thousands of nanoliter-sized droplets and counting the fraction of positive droplets after end-point PCR, ddPCR provides highly precise and reproducible quantification, particularly at low target concentrations [6]. In the context of OsHV-1, ddPCR has been employed to quantify host immune gene expression in hemocytes following exposure to inactivated viral antigens [6]. Its potential for viral load quantification in epidemiological surveys is promising, especially for detecting low-abundance viral genomes in environmental samples or in carrier oysters. However, ddPCR is more costly and less widely adopted than qPCR, and its use in OsHV-1 diagnostics remains limited to specialized research applications.

Advanced Molecular Characterization: Sequencing Approaches

Sanger Sequencing for Targeted Genotyping

Sanger sequencing of PCR amplicons is the standard method for confirming the identity of OsHV-1 variants and distinguishing microvariant genotypes from the reference genotype. The microvariant is defined by a deletion of 12–13 base pairs in the C region, and sequencing of this region, along with ORF42/43, has been used to characterize isolates from France, Ireland, Australia, Korea, and Argentina [2, 10, 21, 31]. Although Sanger sequencing provides only a consensus sequence of the dominant variant in a sample and may miss minor intrapopulation diversity, it remains a rapid and cost-effective genotyping tool.

Whole-Genome Sequencing with Short Reads (Illumina)

The application of Illumina short-read sequencing has revolutionized the study of OsHV-1 population genomics and molecular epidemiology. Whole-genome sequencing of viral isolates from infected oysters has enabled the detection of single nucleotide polymorphisms (SNPs), the reconstruction of phylogenetic relationships, and the inference of viral dispersal patterns. Studies employing Illumina sequencing have revealed distinct geographic clustering of OsHV-1 genotypes in Australian estuaries [21] and have traced the likely origin and spread of the virus among oyster farming areas in France, identifying Marennes-Oléron Bay as a major source of viral diversity [47]. However, the OsHV-1 genome is characterized by complex genomic architecture, including tandem repeats, inverted repeats, and the presence of multiple genomic isomers. Short-read sequencing struggles to assemble these repetitive regions accurately and cannot resolve large structural variations, limiting its utility for fully characterizing the viral genome [22, 30].

Long-Read Sequencing (Nanopore) for Complete Genome Characterization

Third-generation sequencing technologies, particularly Oxford Nanopore Technologies (ONT), have overcome many of the limitations of short-read approaches. ONT sequencing produces reads exceeding tens of kilobases, enabling the assembly of the complete OsHV-1 genome directly from infected host tissues without the need for prior virus propagation [22, 30]. The development of high-molecular-weight (HMW) DNA extraction protocols tailored for OsHV-1 from oyster tissues has been critical; comparisons of six HMW methods and a conventional kit showed that the HMW kit coupled with ONT sequencing yielded accurate genome assemblies [22, 30]. Furthermore, adaptive sampling (AS) enables real-time enrichment of viral reads, achieving up to 60% viral data from a mixed host-virus sample [22, 30]. Long-read sequencing has also been applied to transcriptomics, revealing the complexity of the OsHV-1 transcriptome with 274 transcripts, including polycistronic mRNAs, non-coding RNAs, and natural antisense transcripts [32]. This technology has identified a conserved pan-Herpesvirales transcriptional architecture for the capsid maturation module and provided evidence for a mechanism involving ADAR1-mediated RNA editing evasion [32, 44]. The portability of ONT sequencers holds great promise for real-time field diagnostics and genomic surveillance of OsHV-1 during outbreak events.

In Situ Detection Methods

In Situ Hybridization (ISH)

In situ hybridization (ISH) using labeled probes complementary to OsHV-1 DNA or RNA allows the localization of the virus within specific cell types and tissues. ISH has been employed to demonstrate the presence of OsHV-1 in the gill tissue of Crassostrea gigas [3] and to characterize the tissue tropism of the virus in blood clams (Anadara broughtonii), revealing that hemocytes and fibroblastic-like cells are primary cellular targets, with viral signals also detected in gill filaments, mantle connective tissue, foot, and adductor muscle [19]. This technique is invaluable for understanding the cellular pathogenesis of OsHV-1, as it can correlate histological lesions with viral presence at a cellular resolution. However, ISH is labor-intensive, requires specialized equipment, and is not amenable to high-throughput screening.

Immunofluorescence and Histological Techniques

Immunofluorescence assays (IFA) using antibodies directed against viral proteins have been developed to detect OsHV-1 antigens in hemocytes and tissue sections [36]. These methods have been used to confirm viral protein expression in infected cells and to study the inhibition of apoptosis during infection [36]. However, the availability of validated antibodies against OsHV-1 proteins remains limited, and cross-reactivity with host proteins can be a concern. Histological examination using standard hematoxylin and eosin (H&E) staining can reveal characteristic lesions, such as severe hemocytosis with blast-like cells, myocyte degeneration, and the presence of degenerate eosinophilic cells in connective tissue, but these changes are not pathognomonic and require confirmation by molecular or immunologic methods [10].

Transmission Electron Microscopy (TEM)

Transmission electron microscopy (TEM) has been used to visualize herpesvirus particles in infected oyster tissues, providing definitive morphological evidence of viral infection. Herpesvirus particles with characteristic nucleocapsids (~100 nm in diameter) and enveloped virions have been identified in samples from mortality events in France [10, 38], Korea [31], and in tissue explant cultures [53]. TEM is also useful for confirming the presence of the virus in experimental settings, such as after injection of oysters with magnetic bead-captured virus [20]. Despite its high specificity, TEM is low-throughput, requires significant expertise, and does not provide quantitative or genotypic information.

Biosensor and Point-of-Care Methods

Electrochemical Biosensors with Isothermal Amplification

The need for rapid, user-friendly, and field-deployable diagnostic tools has driven the development of biosensors for OsHV-1. One notable platform combines recombinase polymerase amplification (RPA) with an electrochemical readout using miniaturized gold electrodes [52]. In this system, isothermally amplified OsHV-1 DNA is detected through a sandwich hybridization assay with an immobilized thiolated capture probe and a horseradish peroxidase (HRP)-labeled reporter probe, achieving a limit of detection of 207 target copies [52]. When tested on 16 oyster samples from an infectivity experiment, results correlated strongly with qPCR (r = 0.988) [52]. This biosensor is rapid (results in under 2 hours), cost-effective, and potentially suitable for on-site testing in aquaculture facilities, improving the capacity for early intervention.

Magnetic Bead Pre-concentration Combined with qPCR

Magnetic beads (MBs) coated with anionic polymers have been developed to capture OsHV-1 from complex matrices, including oyster homogenate and seawater [20, 49]. The negatively charged polymer interacts with the viral envelope, allowing efficient adsorption. Captured virus can be detected by qPCR, and importantly, the virus remains viable, as demonstrated by injection of MB-virus conjugates into naïve oysters, which induced mortality [20]. When applied to seawater, the MB-qPCR approach achieved a limit of detection as low as 0.1 viral copy/μL, representing a 100-fold improvement over qPCR alone [49]. This method has been used to monitor viral release kinetics in seawater and to verify the efficacy of UV disinfection treatments, where qPCR alone could not discriminate between UV-treated and untreated seawater [49]. The MB pre-concentration step is rapid, simple, and enhances the sensitivity of downstream molecular detection, making it an important tool for environmental surveillance and hatchery biosecurity.

Detection in Diverse Sample Types and Host Species

OsHV-1 can be detected in a range of sample types, including whole oyster homogenates, gill tissue, mantle, hemolymph, and seawater. In experimental infections, gill and hemolymph often yield the highest viral loads [19, 36]. Hemolymph sampling is advantageous because it can be performed non-lethally, allowing repeated sampling of the same individual over time [36]. Seawater surveillance is critical for early warning systems, as the virus can be present in the water column before infections become clinically apparent in oysters [20, 49]. The ability of OsHV-1 to infect multiple bivalve species, including Pacific oysters (C. gigas), Portuguese oysters (C. angulata), Kumamoto oysters (C. sikamea), Eastern oysters (C. virginica), bay scallops (A. irradians), hard clams (Mercenaria mercenaria), blood clams (A. broughtonii), and mussels (Mytilus spp.), necessitates the validation of diagnostic assays across taxa [9, 14, 17, 31]. Furthermore, the detection of OsHV-1 in non-bivalve taxa such as crustaceans (shore crabs Carcinus maenas) and polychaetes suggests a broader ecological role for these species as potential vectors or carriers, highlighting the importance of diagnostic testing in the wider invertebrate community [14].

Quantification and Interpretation of Viral Load

The interpretation of qPCR results requires standardized reporting units to enable comparison across studies. Viral load is typically expressed as OsHV-1 DNA copies per ng of total DNA extracted, per mg of tissue (wet weight), or per μL of hemolymph. Thresholds for disease association vary, but mortality in experimental challenges is consistently linked to viral loads exceeding 10⁶ copies per ng DNA or 10⁶ copies per mg tissue [4, 17, 24]. Subclinical infections, characterized by lower viral loads (<10⁴ copies) and the absence of detectable viral RNA, are frequently observed in surviving oysters and in field surveys during non-outbreak periods [8, 51]. Latent infection, as recently demonstrated through detection of viral DNA in hemocytes in the absence of lytic gene transcription and reactivation induced by chemical or temperature stress, adds another layer of complexity [51]. Distinguishing latent from active infection requires combined DNA and RNA analysis, as DNA detection alone does not indicate replicative status. The use of digital PCR may improve the precision of quantification at the low end of the detection range, but is not yet routinely applied in diagnostic settings.

Quality Control, Standardization, and WOAH Considerations

For a pathogen of such economic and regulatory importance, the establishment of standardized diagnostic protocols is essential. The WOAH Manual of Diagnostic Tests for Aquatic Animals provides guidelines for the detection of OsHV-1, recommending qPCR as the primary diagnostic method and confirming the need for sequencing of the C region to differentiate microvariants. Inter-laboratory validation studies, such as those conducted during the Australian national surveillance program, highlight the challenges of test validation when epidemiological data are limited, and underscore the need for certified reference materials and proficiency testing [48]. Factors influencing assay performance include the efficiency of DNA extraction, the choice of target region, primer and probe design, and the presence of PCR inhibitors in molluscan tissues. The development of internal amplification controls and the use of standardized positive controls are recommended to ensure assay reliability. As sequencing technologies become more accessible, the integration of whole-genome approaches into routine surveillance may allow for more nuanced characterization of viral diversity and the tracking of emergent variants with altered virulence [21, 22, 47].

Future Directions in Diagnostics

The future of OsHV-1 diagnostics is likely to be shaped by portable sequencing technologies, multiplexed biosensors, and the integration of multi-omic data. Long-read nanopore sequencing, with its ability to generate complete viral genomes directly from field samples in near real-time, offers a paradigm shift for outbreak response and molecular epidemiology [22, 30, 32]. The development of viability assays, such as PMA-qPCR [45] and RNA-based detection, will improve the assessment of infectious risk. Point-of-care devices based on isothermal amplification and electrochemical detection are entering the field and could empower on-farm decision-making [52]. Furthermore, the integration of host transcriptomic signatures, such as the expression of antiviral genes like interferon-like pathway components or RNA interference factors, could lead to diagnostic algorithms that predict disease outcome based on host response [13, 18]. As climate change and global trade continue to influence the distribution and virulence of OsHV-1, robust, standardized, and field-deployable diagnostic methods will remain central to the management of the disease.

Virulence Variation and Genetic Diversity Among OsHV-1 Isolates

The Ostreid herpesvirus 1 (OsHV-1) complex, encompassing the reference genotype and its numerous microvariants (µVars), represents a paradigmatic example of a viral pathogen whose ecological and economic impact is profoundly shaped by intraspecific genetic and phenotypic heterogeneity. Since the emergence of the first microvariant in France in 2008 [38], the global dissemination of OsHV-1 has been accompanied by a remarkable diversification, yielding isolates that exhibit substantial differences in virulence, transmissibility, host range, and genomic architecture. Understanding the drivers and consequences of this variation is not merely an academic exercise; it is fundamental to predicting disease emergence, designing effective surveillance programs, and developing sustainable management strategies, including selective breeding and immune priming protocols. This section provides an exhaustive analysis of the documented virulence variation among OsHV-1 isolates, the molecular and genomic underpinnings of this diversity, and the epidemiological context that shapes its expression.

Temporal and Geographical Variation in Virulence

One of the most compelling lines of evidence for virulence variation among OsHV-1 isolates comes from longitudinal studies in endemic regions. In Australia, a landmark study by Cain et al. [1] directly compared the virulence of three OsHV-1 isolates collected from the same endemic waterways between 2011 and 2015. Using a standardized in vivo laboratory infection model, they demonstrated a significant temporal reduction in virulence. The isolate obtained in 2011 induced a significantly higher hazard of death and cumulative mortality compared to isolates from 2014–2015, despite all isolates being collected during active disease outbreaks. This attenuation was observed across multiple metrics, including total cumulative mortality, peak viral load, and transmissibility via cohabitation. Importantly, the quantity of OsHV-1 DNA at the time of death did not differ between isolates, suggesting that the pathogenetic processes leading to end-stage disease were similar, but the overall capacity to establish a lethal infection had diminished. This finding aligns with broader epidemiological observations from the same region, where Whittington et al. [8] documented a significant reduction in both mortality due to OsHV-1 and the prevalence of subclinical infections in sentinel spat between the 2012–13 and 2016–17 seasons. Viral loads in infected oysters also appeared to decline over this period. These data collectively suggest a natural attenuation of virulence over time in an endemic setting, potentially driven by host adaptation, viral evolution towards reduced pathogenicity, or a combination of both. The authors [1] propose that surveillance for low-virulence genotypes could be rewarding, potentially opening avenues for controlled exposure to attenuated strains as a management tool.

Conversely, the emergence of highly virulent microvariants in new geographical regions has been associated with catastrophic mortality events. The initial emergence of OsHV-1 µVar in France in 2008 [38] and its subsequent spread to Australia (2010), New Zealand, and the United States [4, 5, 17] underscores the capacity for certain genotypes to exhibit extreme virulence in naïve host populations. Agnew et al. [4] provided a critical comparative analysis by directly challenging Pacific oyster juveniles with three distinct variants: a California reference OsHV-1 (non-µVar), an Australian µVar, and a French µVar. The survival probability of oysters exposed to the French (43%) or Australian (71%) µVar was significantly lower than that of oysters exposed to the reference variant (96%). This study was the first to directly demonstrate that µVars are inherently more virulent than the reference genotype in a controlled setting, confirming field observations. The differential virulence between the French and Australian µVars (43% vs. 71% survival) further highlights that even within the microvariant group, significant phenotypic variation exists. This was corroborated by Friedman et al. [17], who found that mortality in Pacific oyster stocks challenged with the French µVar (~72%) was higher than with the Australian µVar (~22%) in one stock, while the opposite pattern was observed in Kumamoto oysters (C. sikamea). This stock-by-isolate interaction underscores the complex interplay between host genetics and viral genotype in determining disease outcome.

The phenomenon of virulence variation is not limited to comparisons between reference and microvariant genotypes. Within the µVar group itself, novel divergent clusters have been identified. Burioli et al. [10] characterized a novel group of OsHV-1 µVar variants associated with a mortality event in Normandy, France, in 2016. Sequencing of 30 open reading frames (ORFs) across 20 individuals revealed seven distinct genotypes, with the highest number of variations occurring in ORFs encoding putative membrane proteins. Phylogenetic analysis placed these variants in a well-separated new group, with an estimated evolutionary divergence of 0.0013 from other µVar variants. The effective virulence of these newly described variants requires further investigation, but their discovery highlights the ongoing diversification of the virus. Similarly, in Japan, Nagai and Nakamori [23] characterized the pathogenicity of OsHV-1 JPType1, a Japanese variant, and confirmed its ability to cause mortality in larvae and spat, with virulence declining as oysters grew. The existence of geographically distinct clusters is further supported by the work of Trancart et al. [21], who found that Australian OsHV-1 genotypes formed a globally distinct cluster and that distinct genotypes were geographically clustered within individual estuaries. Notably, they concluded that Australian POMS outbreaks were not due to OsHV-1 microvariants as defined by European criteria, suggesting that the term "microvariant" may encompass a broader range of genetically and phenotypically distinct lineages than initially appreciated.

Genomic Architecture and the Molecular Basis of Diversity

The genetic diversity underlying virulence variation is now being elucidated through advanced genomic and transcriptomic approaches. The OsHV-1 genome, a large double-stranded DNA molecule of approximately 207 kbp, presents a complex architecture that includes multiple genomic isomers, tandem repeats, and repeat regions that have historically been challenging to assemble using short-read sequencing technologies [22, 30]. The application of long-read sequencing, particularly Oxford Nanopore Technologies (ONT) with adaptive sampling, has revolutionized the ability to characterize OsHV-1 genomes directly from infected host tissues [22, 30]. Dotto-Maurel et al. [22] demonstrated that ONT sequencing, coupled with high molecular weight DNA extraction and dedicated bioinformatics pipelines, could produce accurate OsHV-1 genomes and characterize structural variations and isomers that were previously inaccessible. This technological leap is critical for understanding the full extent of genomic diversity, including large structural variations that may underpin virulence differences.

The most extensively studied genomic region for diversity is the "C region" (ORFs 42/43), which is used for microvariant classification. However, the diversity extends far beyond this locus. Burioli et al. [10] found that ORFs encoding putative membrane proteins were the most variable, suggesting that these surface-exposed proteins may be under strong selective pressure from the host immune system. This is consistent with the role of membrane proteins in host cell recognition, entry, and immune evasion. The transcriptomic complexity of OsHV-1 is also remarkable. Rosani et al. [32] used long-read RNA sequencing to annotate the OsHV-1 genome with 78 gene units and 274 transcripts, including 67 polycistronic mRNAs, 35 non-coding RNAs, and 20 natural antisense transcripts (NATs). This complexity provides multiple layers of potential regulatory variation that could influence virulence. For example, they identified a conserved pan-Herpesvirales transcriptional architecture for the capsid maturation module, suggesting that even fundamental replication processes are subject to transcriptomic regulation. Furthermore, they uncovered a potential mechanism for evasion of the host ADAR-based antiviral defense system, where OsHV-1 generates "molecular decoys" by co-expressing sense-antisense transcripts that sequester ADAR-mediated RNA hyper-editing [32, 44]. This represents a sophisticated viral counter-defense that could vary between isolates and contribute to differences in host susceptibility.

Phylogeographic analyses have begun to trace the dispersal of OsHV-1 diversity. Delmotte et al. [47] used ultra-deep sequencing on individual moribund oysters from three main French oyster-farming areas to de novo assemble 21 new OsHV-1 genomes. By combining major and minor genetic variations with ancestral state reconstruction, they demonstrated that the Marennes-Oléron Bay appears to be the main source of OsHV-1 diversity in France, from which the virus has dispersed to other farming areas. This pattern is consistent with the known practice of oyster transfers in France and provides a framework for understanding how genetic diversity is generated and spread. The study also highlighted that phylodynamic approaches, typically applied to RNA viruses, can be successfully adapted to large DNA viruses like OsHV-1, offering new insights into the epidemiological and evolutionary processes shaping diversity.

Host-Pathogen Interactions and Genetic Determinants of Virulence

The expression of virulence is not a fixed property of a viral isolate but is modulated by the genetic background of the host, environmental conditions, and the co-occurring microbial community. The genetic basis of host resistance has been a major focus of research, with several studies identifying quantitative trait loci (QTL) and candidate genes associated with survival. Divilov et al. [7] performed genome-wide allele frequency studies in Pacific oyster families and identified six significant QTL on chromosome 8, all of which were assigned to candidate genes (ABCA1, PIK3R1, and WBP2) that have previously been associated with antiviral innate immunity in vertebrates. This reinforces the evolutionary conservation of antiviral pathways between mollusks and vertebrates. Yao et al. [11] used pooled whole-genome resequencing of larvae and adults to identify thousands of SNPs and genomic regions associated with OsHV-1-caused mortality. Critically, they found that only 1,653 of the implicated genes were shared between larvae and adults, suggesting that the antiviral response or resistance mechanisms differ substantially between developmental stages. Key immune response genes, particularly those encoding antiviral receptors such as TLRs and RLRs, displayed strong associations between regulatory region variation and mortality, indicating that transcriptional modulation of these receptors may confer resistance.

At the molecular level, proteomic and transcriptomic studies have revealed the intricate battle between the virus and the host. Leprêtre et al. [13] used comparative proteomics on two oyster families with contrasted susceptibility to OsHV-1. They detected seven viral proteins in infected oysters, some with potential immunomodulatory functions, and found that the more susceptible family showed evidence of viral manipulation of the host's autophagy system. This immunomodulation may be a key virulence mechanism. Conversely, the more resistant family showed activation of proteins involved in RNA interference, an interferon-like pathway, and antioxidant defense. The role of autophagy was further explored by Picot et al. [40], who demonstrated that autophagy is activated in hemolymph and mantle 14 hours post-infection, with different regulatory mechanisms in the two tissues. The ability of OsHV-1 to inhibit apoptosis is another critical virulence determinant. Martenot et al. [36] showed that OsHV-1 infection in hemocytes is associated with the down-regulation of pro-apoptotic genes (TNF, caspase 3) and up-regulation of anti-apoptotic genes (IAP-2, Bcl-2), leading to an inhibition of the apoptotic process. This allows the virus to maintain the viability of infected cells for replication. The expression of a putative apoptosis inhibitor (ORF 87) was detected, providing a direct molecular mechanism for this immune evasion strategy.

The host's nutritional and metabolic state also profoundly influences the outcome of infection. Duperret et al. [43] demonstrated that starvation reduces oyster susceptibility to POMS. Through integrative omics, they showed that starvation induces metabolic rate depression, which may limit viral replication by reducing the availability of cellular energy, and enhances autophagy and antiviral responses. This suggests that the metabolic environment of the host cell is a critical determinant of viral replication efficiency and, consequently, virulence. Similarly, Fuhrmann et al. [37] found that oysters with higher antioxidant activity and better physiological condition (higher protein, carbohydrate, and triglyceride levels) were less susceptible to OsHV-1, linking host metabolic reserves to disease resistance.

Environmental Modulation of Virulence Expression

The expression of virulence by a given OsHV-1 isolate is exquisitely sensitive to environmental conditions, particularly temperature, salinity, and pH. Water temperature is arguably the most critical abiotic factor. Kantzow et al. [24] established a clear temperature threshold for disease expression, showing that mortality was 84% and 77% at 26°C and 22°C, respectively, compared to 23% at 18°C and nil at 14°C. Importantly, they found a significant interaction between temperature and viral dose: at 18°C, mortality only occurred with a high dose (10⁶ copies/oyster), whereas at higher temperatures, a dose as low as 10³ copies was lethal. This indicates that temperature not only affects the host's ability to control infection but also lowers the effective virulence of the virus by reducing the infectious dose required. Kunselman et al. [28] confirmed that the San Diego Bay microvariant could replicate at 15°C but did not induce mortality until temperatures exceeded this threshold. Duperret et al. [29] provided mechanistic insight, showing that high temperature (30°C) has a dual effect: it induces metabolic reprogramming that creates a sub-optimal environment for viral replication and enhances the host's antiviral immune capabilities. This explains why POMS outbreaks are typically associated with warm summer months [8].

Salinity is another potent modulator of virulence. Fuhrmann et al. [12] demonstrated that acclimation to low salinity (10‰) resulted in 95% survival of oysters exposed to OsHV-1, compared to only 43-73% at higher salinities (15-35‰). This was associated with lower levels of OsHV-1 DNA and viral gene expression. However, the protective effect was lost if oysters were not acclimated, with non-acclimated oysters at 10‰ suffering 23% mortality, likely due to salinity shock. The metabolic basis for this protection was explored by Fuhrmann et al. [37], who found that low salinity acclimation led to increased energetic reserves and altered membrane fatty acid composition, which may enhance the host's ability to mount an effective antiviral response. Reduced seawater pH, a consequence of ocean acidification, also increases susceptibility. Fuhrmann et al. [27] found that survival of oysters exposed to OsHV-1 at pH 7.8 was lower (33.5%) than at pH 8.1 (44.8%), despite similar viral loads. This was associated with reduced activities of superoxide dismutase (SOD) and nitric oxide synthase (iNOS), key components of the antioxidant and immune response.

The polymicrobial nature of POMS further complicates the virulence landscape. OsHV-1 infection is often followed by a secondary bacterial infection, particularly by Vibrio species, which contributes to mortality [28, 34]. Pathirana et al. [34] found a strong correlation between OsHV-1 and Vibrio quantities in infected oysters, and oysters with higher Vibrio loads experienced higher mortality. Kunselman et al. [28] showed that OsHV-1 infection leads to a significant shift in the oyster tissue-associated bacterial community, with an initial increase in richness followed by a decrease as oysters became moribund. Four bacterial taxa (Arcobacter, Vibrio, Amphritea, and Pseudoalteromonas) were consistently associated with infection across geographically distinct microvariant types, suggesting a conserved polymicrobial pathogenesis. This

Host-Pathogen Interactions and Disease Progression in Oysters

The interplay between Ostreid herpesvirus 1 (OsHV-1) and its bivalve hosts, particularly the Pacific oyster Crassostrea gigas (now also referred to as Magallana gigas), constitutes a dynamic and multifaceted biological process that is fundamentally different from herpesvirus infections in vertebrates. Disease progression is not a simple linear event but a complex, stage-dependent cascade that is profoundly influenced by viral genotype, host genetic background, environmental conditions, and the composition of the associated microbial community. This section provides an exhaustive analysis of the molecular and cellular mechanisms governing this interaction, from initial viral entry and replication through to the dysregulation of host physiology that culminates in mortality.

Pathogenesis and the Infectious Cycle of OsHV-1

The initiation of a productive OsHV-1 infection is contingent upon the virus overcoming the oyster's physical and immunological barriers. Following exposure, the virus is believed to enter the host primarily through the epithelia of mucosal surfaces, with the gills and mantle serving as crucial portals of entry [2, 19]. Within the host, the virus demonstrates a clear tissue and cellular tropism. Quantitative PCR, histopathology, and in situ hybridization studies in both Pacific oysters and blood clams (Anadara broughtonii) have identified hemocytes and fibroblastic-like cells as the primary cellular targets for viral replication [19]. Hemocytes, the circulating immune cells of bivalves, are of particular significance; their infection not only provides a cellular factory for viral propagation but also serves as a vector for systemic dissemination throughout the connective tissues of various organs, including the mantle, hepatopancreas, gills, and adductor muscle [19, 36]. This systemic spread is associated with progressive tissue damage, necrosis, and the infiltration of infected hemocytes into connective tissues, leading to widespread histopathological lesions [2, 10, 19].

The replicative cycle of OsHV-1, as elucidated through dual transcriptomics and time-course infection experiments, involves a rapid and well-coordinated cascade of gene expression. Upon entry, the virus hijacks the host cellular machinery. A temporal analysis of viral gene expression reveals an initial phase dominated by immediate-early and early genes, including those encoding putative enzymes like dUTPase (ORF 75) and proteins involved in immune modulation [36, 46]. These are followed by the expression of late genes encoding structural proteins, such as nucleocapsid and putative membrane proteins (e.g., ORFs 25, 41, 72) [36]. The replication of viral DNA and transcription of these genes are tightly correlated with the viral load, which increases exponentially during the early stages of infection, peaking just prior to the onset of mortality [1, 4, 46]. The World Organisation for Animal Health (WOAH) recognizes OsHV-1 as a significant pathogen of molluscs, and the high viral loads observed in moribund animals, often exceeding 10⁸ DNA copies per mg of tissue, are a hallmark of end-stage disease [1, 4, 39].

Host Immune Recognition and Antiviral Signaling

Despite the absence of a classical adaptive immune system, Pacific oysters possess a sophisticated and multilayered innate immune system capable of recognizing and responding to viral infection. The initial recognition of viral pathogen-associated molecular patterns (PAMPs), such as double-stranded RNA (dsRNA), is mediated by pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) [11, 13, 25]. Genomic studies have identified strong associations between genetic variation in the regulatory regions of these receptors and survival during OsHV-1 outbreaks, underscoring their critical role in antiviral defense [11].

Upon activation, these PRRs initiate signaling cascades that converge on central hubs. The myeloid differentiation primary response 88 (MyD88) adaptor protein is a linchpin in TLR signaling. C. gigas possesses multiple MyD88-like proteins, including CgMyD88-1, CgMyD88-2, and a unique truncated form, CgMyD88s, which lacks a death domain. Intriguingly, CgMyD88s acts as a negative regulator, "plugging" the signaling pathway to prevent excessive inflammation, a mechanism that may be subverted during infection [25]. Downstream signaling leads to the activation of transcription factors like NF-κB, which drive the expression of antiviral effector genes [25, 46]. Proteomic analyses have confirmed the activation of an interferon-like pathway, a cornerstone of antiviral immunity in mammals, as well as the RNA interference (RNAi) machinery, which is a potent antiviral mechanism in invertebrates [13, 42]. The importance of the RNAi pathway is further highlighted by the observation that injection of long dsRNA molecules, even non-specific ones like GFP-dsRNA, can induce a potent antiviral state that largely suppresses OsHV-1 replication, demonstrating a robust, non-specific innate immune response [42].

Manipulation of Host Cell Death Pathways: Apoptosis and Autophagy

A central battleground in OsHV-1 infection is the control of host cell survival and death. Apoptosis, a programmed cell death mechanism, is a fundamental antiviral strategy used to limit viral replication by eliminating infected cells. However, OsHV-1 has evolved sophisticated countermeasures. Gene expression studies in experimentally infected oysters have revealed a potent anti-apoptotic state orchestrated by the virus. This is characterized by the downregulation of pro-apoptotic genes (e.g., TNF and caspase-3) and the concurrent upregulation of anti-apoptotic genes, notably inhibitors of apoptosis (IAP-2) and Bcl-2 family members [36]. Furthermore, the OsHV-1 genome itself encodes a putative apoptosis inhibitor (ORF 87), whose transcripts are highly expressed during infection [36]. Functional assays confirm this manipulation; hemocytes collected from OsHV-1-infected oysters show significantly less phosphatidylserine externalization and DNA fragmentation, hallmarks of apoptosis, compared to hemocytes from uninfected controls [36]. By actively suppressing apoptosis, the virus ensures the survival of its cellular factory long enough to complete its replication cycle and produce progeny virions.

Conversely, the role of autophagy appears more complex and nuanced. Autophagy is a cellular degradation pathway that can act as both an antiviral mechanism and, in some cases, be subverted to benefit the pathogen. In Pacific oysters, autophagy is conserved and functional. Experimental infection trials, combined with the use of autophagy modulators, have demonstrated that the autophagy pathway is activated in hemolymph and mantle tissue at approximately 14 hours post-infection, coinciding with the onset of active viral replication [40]. Proteomic data further suggest that in oyster families particularly susceptible to OsHV-1, the virus may manipulate the host's autophagy machinery to its own advantage, potentially weakening the host and triggering cell death [13]. The delicate balance between protective autophagy and virus-mediated subversion is a critical determinant of disease outcome.

Genetic Determinants of Susceptibility and Resistance

The outcome of OsHV-1 infection is profoundly influenced by the host's genetic background. Selective breeding programs have long demonstrated significant heritable variation in survival rates during outbreaks, and research has successfully identified specific genomic regions, or quantitative trait loci (QTL), associated with resistance [4, 7, 11, 17, 39, 46]. Notably, a major QTL on chromosome 8 has been repeatedly linked to basal antiviral gene expression and survival in Tomales Bay, California [7]. Fine-mapping of this locus has identified candidate genes, including ABCA1, PIK3R1, and WBP2, which are known to be involved in antiviral innate immunity in vertebrates, highlighting the conservation of core immune pathways across the animal kingdom [7].

The genetic architecture of resistance is, however, developmental stage-specific and pathogen-strain-specific. Pooled whole-genome resequencing studies have shown that only a minority of genes implicated in surviving OsHV-1 challenge are shared between larvae and adults, suggesting that distinct antiviral mechanisms operate at different life stages [11]. Furthermore, resistance is not universal. Oyster families selected for survival against one viral genotype may be highly susceptible to another. For example, a stock of C. gigas that showed 78% survival against an Australian µVar experienced 28% survival when challenged with a French µVar, while the reverse pattern was observed in Kumamoto oysters (C. sikamea) [17]. This underscores that resistance is a complex, polygenic trait that is often specific to the viral variant in question [4, 17]. Importantly, surviving oysters frequently harbor extremely high loads of viral DNA (mean ~3.53 × 10⁸ copies), indicating that surviving families exhibit tolerance, i.e., they can tolerate a high pathogen burden without succumbing to disease, rather than resistance, which is the ability to prevent or limit infection [4]. This distinction has profound implications for breeding programs and disease management.

Environmental Modulation of Pathogenesis and the Polymicrobial Nature of POMS

Disease progression is not solely an interaction between the virus and the host but is critically shaped by the environment. Seawater temperature is the most potent environmental determinant. A clear temperature threshold exists below which productive infection does not occur. Laboratory experiments demonstrate that OsHV-1 can replicate but does not cause mortality at 14-15°C; mortality is triggered only above 18°C, with full disease expression seen at 22°C and above [24, 28]. The molecular basis for this has been elucidated using integrative multi-omics approaches. High temperatures (e.g., 30°C) can paradoxically reduce mortality by inducing a metabolic reprogramming that creates a sub-optimal environment for viral replication and by enhancing the host's baseline and induced antiviral immune capabilities [29]. Salinity is another critical factor. Low salinity (10‰) can protect oysters from OsHV-1-induced mortality, but this is contingent upon proper acclimation. If oysters are not acclimated, the osmotic shock itself causes mortality, obscuring the role of the virus [12]. The protective effect at low salinity is linked to shifts in the oyster's energy metabolism and antioxidant capacity; animals in better physiological condition appear less susceptible [12, 37].

The host's nutritional state also plays a paradoxical role. Starvation has been shown to enhance resistance to POMS, apparently by inducing metabolic rate depression, which limits the pool of cellular energy (ATP) available for viral hijacking, and by enhancing autophagy and other antiviral responses [43]. Conversely, exposure to environmental pollutants, such as a mixture of pesticides at realistic concentrations, can increase oyster susceptibility to OsHV-1, leading to higher mortality following infection [45].

Critically, OsHV-1 infection is the initiator, but not the sole cause, of Pacific Oyster Mortality Syndrome (POMS). POMS is a true polymicrobial disease. OsHV-1 infection causes a breakdown of host epithelial barriers and a suppression of the immune system, particularly through the inhibition of apoptosis [28, 36]. This creates an immunological vacuum, allowing opportunistic bacteria, especially Vibrio species (e.g., V. splendidus, V. aestuarianus), to proliferate and cause a secondary, fatal septicemia [28, 34]. A strong correlation exists between OsHV-1 and Vibrio loads in moribund oysters, and the bacterial community composition shifts dramatically during infection [28, 34]. This polymicrobial cascade is the ultimate cause of death, making POMS a complex pathobiosis.

Viral Latency, Immune Priming, and Virulence Evolution

The epidemiological persistence of OsHV-1 in endemic areas is facilitated by its ability to establish latent infections. In a landmark study, OsHV-1 was shown to become latent in adult Pacific oysters, with the genome persisting in hemocytes [51]. This latency is not permanent; it can be reactivated in response to specific stresses, particularly chemical stress (e.g., sodium butyrate) and temperature shock [51]. This reactivation potential provides a mechanism for the source of the virus that initiates new seasonal outbreaks, as latently infected adults may shed virus when environmental conditions become permissive [15, 51].

Despite lacking a canonical adaptive immune system, oysters exhibit a form of immune memory or priming. Prior sub-lethal exposure to OsHV-1, whether through natural infection, injection with heat-inactivated virus, or even the viral mimic poly I:C, can confer significant protection against a subsequent lethal challenge [15, 16, 26, 35]. This protection is associated with a 0.18 to 0.02-fold reduction in the hazard of death compared to naïve controls [16]. Remarkably, this protective effect can be passed to the next generation (transgenerational immune priming), with larvae showing higher survival when their mothers, but not fathers, were exposed to poly I:C prior to spawning, suggesting maternal provisioning of antiviral compounds [26]. While the specific mechanisms remain under investigation, this priming phenomenon provides a powerful tool for potential disease management strategies.

Finally, the virus itself is not evolutionarily static. Longitudinal studies in Australia have documented a measurable reduction in virulence of OsHV-1 microvariants between 2011 and 2015, with more recent isolates inducing significantly lower cumulative mortality and a slower rate of disease progression [1]. This suggests that natural selection may favor less virulent genotypes that allow for host survival and longer transmission windows. The evolution of virulence is a dynamic process, and continued genomic surveillance, now enhanced by long-read sequencing technologies like Oxford Nanopore, is essential to track the emergence and spread of new, potentially more dangerous variants [1, 10, 21, 22]. The genetic diversity of OsHV-1 populations is not randomly distributed; phylogeographic analyses of French oyster-farming areas suggest that Marennes-Oléron Bay acts as a major source population, from which the virus disperses to other regions, likely facilitated by the transfer of live oysters [47]. This connectivity underscores the importance of biosecurity measures in limiting the spread of this devastating pathogen.

Disease Management Strategies and Surveillance of OsHV-1

The management of Ostreid herpesvirus 1 (OsHV-1) and its associated Pacific Oyster Mortality Syndrome (POMS) represents one of the most formidable challenges in contemporary bivalve aquaculture. Unlike many terrestrial livestock diseases for which vaccines, antiviral therapeutics, and eradication protocols are well-established, OsHV-1 management is constrained by the biological realities of the host, a filter-feeding marine invertebrate lacking a classical adaptive immune system, and the pathogen's complex environmental epidemiology. Consequently, a multifaceted, integrated approach has emerged, combining environmental manipulation, genetic improvement of host stocks, immunological priming strategies, pharmacological interventions, and robust, tiered surveillance frameworks. The World Organisation for Animal Health (WOAH) recognizes OsHV-1 infection as a notifiable disease, underscoring its transboundary significance and the necessity for internationally coordinated control measures.

Environmental and Husbandry-Based Disease Mitigation

The most immediately actionable disease management strategies center on manipulation of the rearing environment to create conditions that are permissive for oyster survival but restrictive for viral transmission and pathogenesis. Water temperature is arguably the most critical single driver of POMS outbreaks. A canonical threshold exists, below which productive infection is abrogated. In laboratory-controlled challenges, mortality is negligible at 14°C and limited at 18°C, even with high viral doses, whereas full disease expression occurs at 22°C and 26°C [24]. This thermal dependency has been corroborated in field settings, where mortality commences when mean water temperature rises above approximately 20°C in Australian estuaries, notably 4–5°C warmer than the initiation threshold observed in Europe [8]. However, the relationship is not purely linear. Intriguingly, exposure to supra-optimal temperatures (30°C) can paradoxically protect oysters via a dual mechanism: metabolic reprogramming that creates a sub-optimal environment for viral replication and concurrent enhancement of baseline antiviral immune capabilities [29]. This complex, non-monotonic relationship suggests that temperature-based risk forecasting must be location-specific and seasonally calibrated.

Salinity exerts a profound, context-dependent influence on disease outcomes. Oysters acclimated to low salinity (10‰) exhibit dramatically higher survival rates (95%) following OsHV-1 exposure compared to those at higher salinities (43–73% survival at 25–35‰) [12]. This protection appears linked to alterations in host metabolism, including increased energetic reserves (carbohydrates, triglycerides) and modulation of antioxidant enzyme activities (superoxide dismutase, catalase) that reduce the risk of death [37]. However, the protective effect of low salinity is contingent upon prior acclimation; non-acclimated oysters subjected to a sudden salinity shock suffer high mortality, likely from osmotic stress rather than direct viral pathogenesis [12]. Thus, practical implementation of salinity manipulation as a management tool is constrained by the risk of acute stress and by the hydrological realities of open estuarine systems.

Tidal position and emersion regimes represent another critical husbandry lever. Field observations in Australia consistently demonstrated a significant protective effect of increased emersion time, with oysters grown at higher intertidal heights experiencing lower POMS mortality [8]. This was initially hypothesized to be mediated through physiological changes induced by air exposure. However, controlled laboratory experiments yielded a surprising counter-result: adult oysters subjected to twice-daily emersion after intramuscular injection of OsHV-1 had significantly higher mortality (67.2%) compared to constantly immersed oysters (11.3%) [41]. This discordance suggests that the field protection conferred by high growing height is primarily due to avoidance of viral exposure, reduced contact with virions in the water column, rather than a beneficial physiological effect on the oyster's antiviral defenses. This has profound implications for farm design, advocating for strategies that reduce pathogen encounter rates rather than attempting to bolster host resistance through emersion stress.

Further environmental factors modulate disease outcomes. Low rainfall and high rates of temperature change (thermal flux) have been identified as antecedent conditions for index cases of POMS in Australia, potentially acting as proxies for stress that increases oyster susceptibility [5]. Reduced seawater pH (7.8 vs. 8.1) decreases survival of infected oysters by compromising antioxidant enzyme pathways (SOD, iNOS) [27]. Pesticide exposure at environmentally realistic concentrations increases susceptibility to OsHV-1, likely through additive physiological stress [45]. Critically, nutritional status also plays a decisive role: food deprivation (starvation) reduces oyster susceptibility to POMS by inducing metabolic rate depression, limiting the cellular energy available for viral hijacking, and by enhancing autophagy and antiviral responses [43]. This finding has counterintuitive management implications, suggesting that controlled feed restriction could be a viable prophylactic strategy, particularly in hatchery or nursery settings.

Selective Breeding and Host Genetic Resistance

The strong heritable component of OsHV-1 resistance has made selective breeding one of the most promising long-term management strategies. Biparental oyster families display dramatically divergent susceptibility to viral challenge, with survival rates ranging from near-total mortality to over 90% depending on family background [46]. This genetic basis has been confirmed through both field and laboratory trials, with selective breeding programs in France, the United States, and Australia successfully reducing mortality during outbreaks [4, 39]. Crucially, the mechanism driving improved survival appears to be tolerance, the ability to limit disease pathology while harboring high viral loads, rather than resistance, the prevention of infection itself. Oyster families selected for survival often contain individuals with mean viral loads of ~3.53 × 10⁸ copies, equivalent to the loads found in moribund oysters [4]. This tolerance strategy, while effective for individual survival, carries the epidemiological risk of creating undetected reservoirs that sustain viral transmission.

Genomic tools are rapidly advancing our understanding of the molecular basis of this tolerance. Genome-wide allele frequency studies have identified a major quantitative trait locus (QTL) on chromosome 8 that is associated with basal antiviral gene expression and survival during OsHV-1 mortality events [7]. Fine-mapping within this QTL has pinpointed candidate genes with established roles in vertebrate antiviral innate immunity, including ABCA1 (involved in lipid metabolism and interferon signaling), PIK3R1 (a regulator of PI3K/Akt signaling), and WBP2 (a transcriptional co-activator) [7]. Pooled resequencing studies comparing larvae and adults before and after mortality events have identified thousands of SNPs and genomic regions associated with survival, revealing that the genetic architecture of resistance differs substantially between developmental stages, with only 1,653 of ~8,000 implicated genes shared between larvae and adults [11]. Key immune receptors, including Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs), show strong associations between variation in regulatory regions and mortality outcomes, suggesting that resistance may be conferred through transcriptional modulation of these sentinel molecules [11].

However, the deployment of genetic resistance faces a critical challenge: genotype-by-pathogen interaction. Oyster families selected for survival against one viral variant do not necessarily show cross-protection against others. In the United States, no oyster family demonstrated resistance to all three variants tested (a California reference strain, an Australian µVar, and a French µVar) [4]. Similarly, Crassostrea sikamea (Kumamoto oyster) suffered lower mortality against the French µVar (~22%) but higher mortality against the Australian µVar (~44%), while Pacific oyster stocks showed the opposite pattern [17]. This suggests that breeding programs must be designed with awareness of the specific viral genotypes circulating in the target region, and that global movement of broodstock or seed could inadvertently introduce susceptibility to novel variants.

Immune Priming and Vaccine Development

The paradigm-shifting discovery that C. gigas possesses a form of immune memory, termed "immune priming", has opened the door to vaccine-like interventions for an invertebrate species. Prior exposure to infectious OsHV-1 confers substantial protection against subsequent lethal challenge, with adult oysters that have survived natural outbreaks showing a 118-fold lower risk of mortality compared to naïve oysters [15]. This protection is not merely a function of survival bias (i.e., removal of susceptible individuals) but reflects a genuine, durable change in the host's immune status. Remarkably, this protection can be induced without active viral replication. Heat-inactivated OsHV-1, delivered by intramuscular injection, reduces the hazard of death by approximately 59% compared to unprimed controls, while infectious OsHV-1 reduces it by 82% [16]. The synthetic double-stranded RNA analog poly(I:C), a potent stimulator of antiviral pathways, provides even more dramatic protection, reducing the hazard of death to 0.02 relative to controls [16].

The mechanistic basis of this priming involves multiple, likely interconnected pathways. Long double-stranded RNA molecules, whether targeting specific oyster genes or a control sequence like GFP, induce a generalized antiviral state that completely blocks OsHV-1 replication and prevents mortality [42]. This response involves the upregulation of key immune genes including Cg-IκB1, Cg-Rel1, Cg-IFI44, Cg-PKR, and Cg-IAP [42]. The MyD88 adaptor proteins, central to Toll-like receptor signaling, also play a critical regulatory role: CgMyD88s, a truncated isoform, serves as a "plug" to prevent excessive inflammatory responses during infection, and its silencing enhances expression of the full-length signaling isoforms CgMyD88-1 and CgMyD88-2 [25]. Transgenerational immune priming has also been demonstrated: larvae from mothers exposed to poly(I:C) prior to spawning show significantly higher survival to OsHV-1 challenge, likely mediated through maternal provisioning of antiviral compounds in eggs rather than through reconfiguration of larval gene expression [26].

The practical development of a pseudo-vaccine requires effective antigen preparation and delivery. In vitro assays using hemocytes from juvenile oysters have identified multiple antigen preparations capable of inducing immune stimulation, including chemically and physically inactivated OsHV-1, viral DNA extracts, and protein preparations, within one hour of exposure, without cytotoxicity [6]. These preparations stimulate reactive oxygen species production and upregulate immune-related gene expression, providing a benchmark for formulation optimization [6]. Critical knowledge gaps remain, including the duration of protection, the optimal dose and delivery mechanism, and whether priming can be effectively deployed at scale under commercial farming conditions [16].

Antiviral Compounds and Nutraceutical Interventions

Pharmacological control of OsHV-1, while less developed than genetic or immunological approaches, has yielded promising candidates. The plant-derived alkaloid berberine hydrochloride (BBH) demonstrates potent antiviral activity against OsHV-1 in blood clams (Anadara broughtonii). Bath immersion at 3 mg/L significantly suppresses viral replication, reducing the expression of ORFs encoding early enzymes, putative membrane proteins, and nucleocapsid proteins during the early stages of infection [50]. Treated individuals achieve 46.67% survival compared to 0% in untreated controls by 96 hours post-infection [50]. This represents the first demonstration of a small-molecule antiviral against a molluscan herpesvirus and establishes a proof-of-concept for pharmacological intervention.

Marine-derived sulphated polysaccharides (SPs) offer another natural approach to disease management. Fucoidans from brown algae and carrageenans from red algae have been evaluated for their immunomodulatory effects in C. gigas. Treatment with κ-carrageenan significantly suppresses viral replication, while fucoidan treatment rendered oysters OsHV-1-negative by Day 8 of a 26-day trial [54]. SPs induce a rapid and prolonged increase in total hemocyte count and lysozyme activity, and alter the ratio of circulating blood cell types [54]. These compounds have the additional advantage of being natural, potentially scalable, and compatible with organic aquaculture certification. However, rigorous field trials and cost-benefit analyses are needed before commercial adoption.

Surveillance Strategies: Principles and Technologies

Effective surveillance for OsHV-1 is foundational to disease management, enabling early detection, delimitation of infected zones, and verification of freedom from infection. The World Organisation for Animal Health (WOAH) provides international standards for surveillance design, emphasizing the need for statistically robust sampling strategies, validated diagnostic tests, and clear case definitions. Australia's national surveillance program for OsHV-1 microvariant in 2011 exemplifies these principles: a two-stage survey was designed to detect at least one infected region at 4% design prevalence with 95% confidence, involving 4,121 samples across multiple states. The program successfully demonstrated freedom from infection in areas outside the known infected zone in New South Wales, while also revealing the challenges of interpreting PCR results with limited test validation data [48]. This activity informed improvements in emergency disease preparedness and highlighted the importance of standardized protocols across laboratories.

Passive surveillance, reporting of abnormal mortality events by farmers, provides the first line of detection. However, the non-specific nature of POMS mortality (often indistinguishable from other causes in early stages) necessitates active surveillance programs for reliable monitoring. Sentinel oyster deployment is a powerful active surveillance tool. Regular deployment of specific-pathogen-free spat at fixed stations allows temporal and spatial mapping of viral activity. A seven-year sentinel program in two Australian estuaries demonstrated that OsHV-1 exposure and mortality are highly seasonal (October to April in the Southern Hemisphere), spatially clustered at scales from meters to kilometers, and declining in severity over consecutive seasons [8]. Key operational lessons included: 1) sentinel surveillance is more reliable at estuary level than at individual bay or site level due to fine-scale clustering of exposure; 2) both triploid and diploid spat are susceptible; and 3) molecular testing is essential to distinguish OsHV-1 mortality from other causes [8].

Molecular detection technologies have advanced substantially. Real-time quantitative PCR (qPCR) remains the gold standard for diagnostic confirmation, targeting conserved regions such as ORF 42/43 or the C region [2, 10]. However, the low concentration of OsHV-1 in seawater, often below detection limits, requires pre-concentration steps. Anionic polymer-coated magnetic beads (MBs) have been validated for capturing viable OsHV-1 from both oyster homogenate and seawater, achieving a limit of detection 100-fold lower than qPCR alone (0.1 viral copy/μL) [49]. Captured virus remains infective, enabling downstream applications including bioassays and disinfection studies [20]. For rapid, point-of-care testing, isothermal amplification methods such as recombinase polymerase amplification (RPA) coupled with electrochemical biosensors offer a promising alternative. This approach achieves a limit of detection of 207 copies and shows strong correlation (r = 0.988) with qPCR results in field samples, while requiring minimal equipment and expertise [52].

Genomic surveillance is entering a new era with long-read sequencing technologies. Oxford Nanopore sequencing, combined with adaptive sampling to enrich for viral reads, can generate complete OsHV-1 genomes directly from infected host tissues without prior virus propagation [22, 30]. This approach resolves complex genomic features, including tandem repeats, structural variations, and genome isomers, that are inaccessible to short-read platforms [22]. The ability to characterize viral genotypes in near-real-time from field samples has profound implications for understanding transmission pathways, tracking the emergence of novel variants, and informing phylogeographic models. For instance,

References

[1] Cain G, Liu O, Whittington R, Hick P. Reduction in Virulence over Time in Ostreid herpesvirus 1 (OsHV-1) Microvariants between 2011 and 2015 in Australia. Viruses. 2021. DOI: https://doi.org/10.3390/v13050946

[2] Barbieri E, Medina C, Vázquez N, Fiorito C, Martelli A, Wigdorovitz A, et al.. First detection of Ostreid herpesvirus 1 in wild Crassostrea gigas in Argentina.. Journal of Invertebrate Pathology. 2019. DOI: https://doi.org/10.1016/j.jip.2019.107222

[3] Batista FM, López-Sanmartín M, Boudry P, Navas JI, Ruano F, Renault T, et al.. Insights on the association between somatic aneuploidy and ostreid herpesvirus 1 detection in the oysters Crassostrea gigas, C. angulata and their F1 hybrids. Aquaculture Research. 2016. DOI: https://doi.org/10.1111/ARE.12613

[4] Agnew M, Friedman CS, Langdon C, Divilov K, Schoolfield B, Morga B, et al.. Differential Mortality and High Viral Load in Naive Pacific Oyster Families Exposed to OsHV-1 Suggests Tolerance Rather than Resistance to Infection. Pathogens. 2020. DOI: https://doi.org/10.3390/pathogens9121057

[5] Whittington RJ, Ingram L, Rubio A. Environmental Conditions Associated with Four Index Cases of Pacific Oyster Mortality Syndrome (POMS) in Crassostrea gigas in Australia Between 2010 and 2024: Emergence or Introduction of Ostreid herpesvirus-1?. Animals. 2024. DOI: https://doi.org/10.3390/ani14213052

[6] Delisle L, Rolton A, Vignier J. Inactivated ostreid herpesvirus-1 induces an innate immune response in the Pacific oyster, Crassostrea gigas, hemocytes. Frontiers in Immunology. 2023. DOI: https://doi.org/10.3389/fimmu.2023.1161145

[7] Divilov K, Merz N, Schoolfield B, Green TJ, Langdon C. Genome-wide allele frequency studies in Pacific oyster families identify candidate genes for tolerance to ostreid herpesvirus 1 (OsHV-1). BMC Genomics. 2023. DOI: https://doi.org/10.1186/s12864-023-09744-0

[8] Whittington R, Liu O, Hick P, Dhand N, Rubio A. Long-term temporal and spatial patterns of Ostreid herpesvirus 1 (OsHV-1) infection and mortality in sentinel Pacific oyster spat (Crassostrea gigas) inform farm management. Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2019.734395

[9] Kachmar M, Reece K, Agnew M, Schreier H, Burge C. Susceptibility of shellfish aquaculture species in the Chesapeake Bay and Maryland coastal bays to ostreid herpesvirus 1 microvariants.. Diseases of Aquatic Organisms. 2024. DOI: https://doi.org/10.3354/dao03775

[10] Burioli E, Varello K, Lavazza A, Bozzetta E, Prearo M, Houssin M. A novel divergent group of Ostreid herpesvirus 1 μVar variants associated with a mortality event in Pacific oyster spat in Normandy (France) in 2016.. Journal of Fish Diseases. 2018. DOI: https://doi.org/10.1111/jfd.12883

[11] Yao S, Li L, Guan X, He Y, Jouaux A, Xu F, et al.. Pooled resequencing of larvae and adults reveals genomic variations associated with Ostreid herpesvirus 1 resistance in the Pacific oyster Crassostrea gigas. Frontiers in Immunology. 2022. DOI: https://doi.org/10.3389/fimmu.2022.928628

[12] Fuhrmann M, Petton B, Quillien V, Faury N, Morga B, Pernet F. Salinity influences disease-induced mortality of the oyster Crassostrea gigas and infectivity of the ostreid herpesvirus 1 (OsHV-1). Aquaculture Environment Interactions. 2016. DOI: https://doi.org/10.3354/AEI00197

[13] Leprêtre M, Faury N, Segarra A, Claverol S, Dégremont L, Palos-Ladeiro M, et al.. Comparative Proteomics of Ostreid Herpesvirus 1 and Pacific Oyster Interactions With Two Families Exhibiting Contrasted Susceptibility to Viral Infection. Frontiers in Immunology. 2021. DOI: https://doi.org/10.3389/fimmu.2020.621994

[14] Soppitt H, Meehan C, Culloty S, Lynch S. Role of native and invasive non-native marine invertebrate species as carriers for pathogens Vibrio spp. and ostreid herpesvirus-1 µVar.. Diseases of Aquatic Organisms. 2025. DOI: https://doi.org/10.3354/dao03844

[15] Liu O, Hick P, Whittington R. The Resistance to Lethal Challenge with Ostreid herpesvirus-1 of Pacific Oysters (Crassostrea gigas) Previously Exposed to This Virus. Viruses. 2023. DOI: https://doi.org/10.3390/v15081706

[16] Kantzow MCd, Hick P, Whittington RJ. Immune Priming of Pacific Oysters (Crassostrea gigas) to Induce Resistance to Ostreid herpesvirus 1: Comparison of Infectious and Inactivated OsHV-1 with Poly I:C. Viruses. 2023. DOI: https://doi.org/10.3390/v15091943

[17] Friedman C, Reece K, Wippel B, Agnew M, Dégremont L, Dhar A, et al.. Unraveling concordant and varying responses of oyster species to Ostreid Herpesvirus 1 variants.. Science of the Total Environment. 2020. DOI: https://doi.org/10.1016/j.scitotenv.2020.139752

[18] Rosani U, Young T, Bai C, Alfaro A, Venier P. Dual Analysis of Virus-Host Interactions: The Case of Ostreid herpesvirus 1 and the Cupped Oyster Crassostrea gigas. Evolutionary bioinformatics online. 2019. DOI: https://doi.org/10.1177/1176934319831305

[19] Li Y, Zhang X, Huang B, Xin L, Wang C, Bai C. Localization and Tissue Tropism of Ostreid Herpesvirus 1 in Blood Clam Anadara broughtonii. Biology. 2024. DOI: https://doi.org/10.3390/biology13090720

[20] Toldrà A, Andree KB, Bertomeu E, Roque A, Carrasco N, Gairín I, et al.. Rapid capture and detection of ostreid herpesvirus-1 from Pacific oyster Crassostrea gigas and seawater using magnetic beads. PLoS ONE. 2018. DOI: https://doi.org/10.1371/journal.pone.0205207

[21] Trancart S, Tweedie A, Liu O, Paul-Pont I, Hick P, Houssin M, et al.. Diversity and molecular epidemiology of Ostreid herpesvirus 1 in farmed Crassostrea gigas in Australia: Geographic clusters and implications for “microvariants” in global mortality events. Virus Research. 2022. DOI: https://doi.org/10.1016/j.virusres.2022.198994

[22] Dotto-Maurel A, Pelletier C, Dégremont L, Heurtebise S, Arzul I, Morga B, et al.. Evaluation of long-read sequencing for Ostreid herpesvirus type 1 genome characterization from Magallana gigas infected tissues. Microbiology spectrum. 2025. DOI: https://doi.org/10.1128/spectrum.02082-24

[23] Nagai T, Nakamori M. Experimental Infection of Ostreid Herpesvirus 1 (OsHV-1) JPType1, a Japanese Variant, in Pacific Oyster Crassostrea gigas Larvae and Spats. Gyobyo kenkyu - Fish pathology. 2018. DOI: https://doi.org/10.3147/jsfp.53.71

[24] Kantzow MCd, Hick P, Becker J, Whittington R. Effect of water temperature on mortality of Pacific oysters Crassostrea gigas associated with microvariant ostreid herpesvirus 1 (OsHV-1 µVar). Aquaculture Environment Interactions. 2016. DOI: https://doi.org/10.3354/AEI00186

[25] Tang X, Huang B, Lin S, Wang W, Zhang G, Li L. CgMyD88s Serves as an Innate Immune System Plug During Ostreid Herpesvirus 1 Infection in the Pacific Oyster (Crassostrea gigas). Frontiers in Immunology. 2020. DOI: https://doi.org/10.3389/fimmu.2020.01247

[26] Lafont M, Gonçalves P, Guo X, Montagnani C, Raftos D, Green T. Transgenerational plasticity and antiviral immunity in the Pacific oyster (Crassostrea gigas) against Ostreid herpesvirus 1 (OsHV‐1). Developmental and Comparative Immunology. 2019. DOI: https://doi.org/10.1016/j.dci.2018.09.022

[27] Fuhrmann M, Richard G, Quéré C, Petton B, Pernet F. Low pH reduced survival of the oyster Crassostrea gigas exposed to the Ostreid herpesvirus 1 by altering the metabolic response of the host. Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2018.12.052

[28] Kunselman E, Manrique D, Burge C, Allard SM, Daniel Z, Mitta G, et al.. Temperature and microbe mediated impacts of the San Diego Bay ostreid herpesvirus (OsHV-1) microvariant on juvenile Pacific oysters. Sustainable Microbiology. 2024. DOI: https://doi.org/10.1093/sumbio/qvae014

[29] Duperret L, Valdivieso A, Kunselman E, Petton B, Morga B, Lorgeril Jd, et al.. Deciphering the molecular mechanisms of oyster resistance to Pacific Oyster Mortality Syndrome (POMS) disease induced by high temperatures.. Science of the Total Environment. 2025. DOI: https://doi.org/10.1016/j.scitotenv.2025.180026

[30] Dotto-Maurel A, Pelletier C, Dégremont L, Heurtebise S, Morga IAB, Chevignon G. Evaluation of long-read sequencing for Ostreid herpesvirus type 1 genome characterization from Magallana gigas infected tissues. bioRxiv. 2024. DOI: https://doi.org/10.1101/2024.08.13.607701

[31] Kim H, Jun J, Giri S, Yun S, Kim SG, Kim SW, et al.. Mass mortality in Korean bay scallop (Argopecten irradians) associated with Ostreid Herpesvirus-1 μVar.. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13200

[32] Rosani U, Bortoletto E, Zhang X, Huang B, Xin L, Krupovic M, et al.. Long-read transcriptomics of Ostreid herpesvirus 1 uncovers a conserved expression strategy for the capsid maturation module and pinpoints a mechanism for evasion of the ADAR-based antiviral defence. bioRxiv. 2024. DOI: https://doi.org/10.1093/ve/veae088

[33] Bai C, Zhang X, Venier P, Gu L, Li Y, Wang C, et al.. Paired miRNA and RNA sequencing provides a first insight into molecular defense mechanisms of Scapharca broughtonii during ostreid herpesvirus-1 infection.. Fish and Shellfish Immunology. 2022. DOI: https://doi.org/10.1016/j.fsi.2022.02.004

[34] Pathirana E, Fuhrmann M, Whittington R, Hick P. Influence of environment on the pathogenesis of Ostreid herpesvirus-1 (OsHV-1) infections in Pacific oysters (Crassostrea gigas) through differential microbiome responses. Heliyon. 2019. DOI: https://doi.org/10.1016/j.heliyon.2019.e02101

[35] Kantzow MCd, Whittington R, Hick P. Prior exposure to Ostreid herpesvirus 1 (OsHV-1) at 18 °C is associated with improved survival of juvenile Pacific oysters (Crassostrea gigas) following challenge at 22 °C. Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2019.04.035

[36] Martenot C, Gervais O, Chollet B, Houssin M, Renault T. Haemocytes collected from experimentally infected Pacific oysters, Crassostrea gigas: Detection of ostreid herpesvirus 1 DNA, RNA, and proteins in relation with inhibition of apoptosis. PLoS ONE. 2017. DOI: https://doi.org/10.1371/journal.pone.0177448

[37] Fuhrmann M, Delisle L, Petton B, Corporeau C, Pernet F. Metabolism of the Pacific oyster, Crassostrea gigas, is influenced by salinity and modulates survival to the Ostreid herpesvirus OsHV-1. Biology Open. 2018. DOI: https://doi.org/10.1242/bio.028134

[38] Schikorski D, Renault T, Saulnier D, Faury N, Moreau P, Pépin J. Experimental infection of Pacific oyster Crassostrea gigas spat by ostreid herpesvirus 1: demonstration of oyster spat susceptibility. Veterinary Research. 2011. DOI: https://doi.org/10.1186/1297-9716-42-27

[39] Evans S, Langdon CJ, Burge CA, Dayal S, Dumbauld B. Monitoring ostreid herpesvirus-1 (OsHV-1) outbreaks in juvenile Pacific oysters Crassostrea gigas along the west coast of the USA.. Diseases of Aquatic Organisms. 2025. DOI: https://doi.org/10.3354/dao03868

[40] Picot S, Faury N, Pelletier C, Arzul I, Chollet B, Dégremont L, et al.. Monitoring Autophagy at Cellular and Molecular Level in Crassostrea gigas During an Experimental Ostreid Herpesvirus 1 (OsHV-1) Infection. Frontiers in Cellular and Infection Microbiology. 2022. DOI: https://doi.org/10.3389/fcimb.2022.858311

[41] Evans O, Kan JZ, Pathirana E, Whittington R, Dhand N, Hick P. Effect of emersion on the mortality of Pacific oysters (Crassostrea gigas) infected with Ostreid herpesvirus-1 (OsHV-1). Aquaculture. 2019. DOI: https://doi.org/10.1016/J.AQUACULTURE.2019.02.041

[42] Pauletto M, Segarra A, Montagnani C, Quillien V, Faury N, Grand JL, et al.. Long dsRNAs promote an anti-viral response in Pacific oyster hampering ostreid herpesvirus 1 replication. Journal of Experimental Biology. 2017. DOI: https://doi.org/10.1242/jeb.156299

[43] Duperret L, Valdivieso A, Petton B, Morga B, Faury N, Lorgeril Jd, et al.. Food deprivation enhances disease resistance: Underlying mechanisms in oysters confronted with pacific oyster mortality syndrome. iScience. 2025. DOI: https://doi.org/10.1016/j.isci.2025.114333

[44] Rosani U, Bortoletto E, Montagnani C, Venier P. ADAR-Editing during Ostreid Herpesvirus 1 Infection in Crassostrea gigas: Facts and Limitations. Msphere. 2022. DOI: https://doi.org/10.1128/msphere.00011-22

[45] Moreau P, Faury N, Burgeot T, Renault T. Pesticides and Ostreid Herpesvirus 1 Infection in the Pacific Oyster, Crassostrea gigas. PLoS ONE. 2015. DOI: https://doi.org/10.1371/journal.pone.0130628

[46] Segarra A, Mauduit F, Faury N, Trancart S, Dégremont L, Tourbiez D, et al.. Dual transcriptomics of virus-host interactions: comparing two Pacific oyster families presenting contrasted susceptibility to ostreid herpesvirus 1. BMC Genomics. 2014. DOI: https://doi.org/10.1186/1471-2164-15-580

[47] Delmotte J, Pelletier C, Morga B, Galinier R, Petton B, Lamy J, et al.. Genetic diversity and connectivity of the Ostreid herpesvirus 1 populations in France: A first attempt to phylogeographic inference for a marine mollusc disease. bioRxiv. 2021. DOI: https://doi.org/10.1093/ve/veac039

[48] Moloney B, Deveney M, Ellard K, Hick P, Kirkland P, Moody N, et al.. Ostreid herpesvirus-1 microvariant surveillance in Pacific oysters (Magallana gigas, Thunberg, 1793) in Australia in 2011.. Australian Veterinary Journal. 2023. DOI: https://doi.org/10.1111/avj.13265

[49] Toldrà A, Andree K, Roque A, Lowenthal A, Rozenberg Y, Furones MD, et al.. Use of anionic polymer-coated magnetic beads to pre-concentrate Ostreid Herpesvirus 1 from seawater: Application to a UV disinfection treatment. Aquaculture. 2021. DOI: https://doi.org/10.1016/J.AQUACULTURE.2021.736452

[50] Kang H, Wei M, Wang J, Ma C, Zhang X, Huang B, et al.. Berberine, a Natural Compound That Demonstrates Antiviral Effects Against Ostreid Herpesvirus 1 Infection in Anadara broughtonii. Viruses. 2025. DOI: https://doi.org/10.3390/v17020282

[51] Divilov K, Wang X, Swisher AE, Yeoman PC, Rintoul MD, Fleener GB, et al.. Ostreid herpesvirus 1 latent infection and reactivation in adult Pacific oysters, Crassostrea gigas. Virus Research. 2023. DOI: https://doi.org/10.1016/j.virusres.2023.199245

[52] Toldrà A, Furones MD, O’Sullivan C, Campàs M. Detection of isothermally amplified ostreid herpesvirus 1 DNA in Pacific oyster (Crassostrea gigas) using a miniaturised electrochemical biosensor.. Talanta: The International Journal of Pure and Applied Analytical Chemistry. 2020. DOI: https://doi.org/10.1016/j.talanta.2019.120308

[53] Potts RWA, Regan T, Ross SH, Bateman KS, Hooper C, Paley R, et al.. Laboratory Replication of Ostreid Herpes Virus (OsHV-1) Using Pacific Oyster Tissue Explants. Viruses. 2024. DOI: https://doi.org/10.3390/v16081343

[54] Lynch S, Breslin R, Bookelaar B, Rudtanatip T, Wongprasert K, Culloty S. Immunomodulatory and Antiviral Effects of Macroalgae Sulphated Polysaccharides: Case Studies Extend Knowledge on Their Importance in Enhancing Shellfish Health, and the Control of a Global Viral Pathogen Ostreid Herpesvirus-1 microVar. Polysaccharides. 2021. DOI: https://doi.org/10.3390/POLYSACCHARIDES2020014